
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Rheumatoid Arthritis (RA) - Musculoskeletal and Connective Tissue Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "85563e6b-c6c5-4019-8939-abf04ba7bed4";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v29657121";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "fd879a9f-14a4-4689-992b-84f1230bed14",
 VasontId : "v905199"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "47e70a29-213f-41bf-be95-acdbe09995db",
 VasontId : "v878831"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="85563e6b-c6c5-4019-8939-abf04ba7bed4">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = '493f7f0b-c884-4c55-9b40-929306f9bc04';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Rheumatoid Arthritis (RA)
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/yaseen-kinanah.html">Kinanah Yaseen</a></strong>
 <p class="topic__authors--description">, MD, Cleveland Clinic</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Nov 2022 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="714.0;714.1;714.2;714.4;714.8" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v29657170" class="topicmenu_mobile__paragraph">Etiology</a>
 </li>
 <li>
 <a href="#v29657173" class="topicmenu_mobile__paragraph">Pathophysiology</a>
 </li>
 <li>
 <a href="#v29657195" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v29657242" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v29657443" class="topicmenu_mobile__paragraph">Prognosis</a>
 </li>
 <li>
 <a href="#v29657448" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v29657474" class="topicmenu_mobile__paragraph">Drugs for Rheumatoid Arthritis</a>
 </li>
 <li>
 <a href="#v29657992" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Calculators'); }, keypress: function() { $data.activateGroup('Calculators'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Calculators (2)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="Rheumatoid Arthritis Clinical Disease Activity Index CDAI">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Rheumatoid Arthritis Clinical...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/RheumatoidArthritisCDAI.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"3d74d960-9d9b-4135-8d15-9aceb916544d","Title":"Rheumatoid%20Arthritis%20Clinical%20Disease%20Activity%20Index%20CDAI","ShareUrlTitle":"rheumatoid-arthritis-clinical-disease-activity-index-cdai","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Rheumatoid%20Arthritis%20Clinical%20Disease%20Activity%20Index%20CDAI","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="Rheumatoid Arthritis Disease Activity Score DAS-28">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Rheumatoid Arthritis Disease...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/RheumatoidArthritisDAS28.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"322331e4-4684-4559-8ec4-37586ada9ef1","Title":"Rheumatoid%20Arthritis%20Disease%20Activity%20Score%20DAS-28","ShareUrlTitle":"rheumatoid-arthritis-disease-activity-score-das-28","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Rheumatoid%20Arthritis%20Disease%20Activity%20Score%20DAS-28","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Images (9)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Swan-Neck Deformity">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="664" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Swan-Neck Deformity
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Swan-Neck Deformity","Credits":"\u003cspan id=\u0022v85662714\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eSCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"aca2f9e8-9ebe-4588-8f1a-a4318c591b86","Title":"Swan-Neck%20Deformity","ShareUrlTitle":"swan-neck-deformity","Description":"%3Cp%3ESwan%20neck%20deformity%20is%20characterized%20by%20extension%20at%20proximal%20interphalangeal%20joint%20and%20flexion%20at%20distal%20interphalangeal%20joint.%20%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v29656882","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"664","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Swan-Neck%20Deformity","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Boutonnière Deformity in Rheumatoid Arthritis">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/b/o/u/boutonniere_deformity_high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="698" loading="lazy">
 </div>
 <span class="hero__description">
 Boutonnière Deformity in...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Boutonnière Deformity in Rheumatoid Arthritis","Credits":"\u003cspan id=\u0022v85653634\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eBy permission of the publisher. From Matteson E, Mason T: Atlas of Rheumatology. Edited by G Hunder. Philadelphia, Current Medicine, 2005.\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"095e8740-1a42-4b39-b531-4e0167ddece9","Title":"Boutonni%C3%A8re%20Deformity%20in%20Rheumatoid%20Arthritis","ShareUrlTitle":"boutonnière-deformity-in-rheumatoid-arthritis","Description":"%3Cp%3EThere%20are%20multiple%20boutonni%C3%A8re%20deformities%20of%20the%20fingers%20and%20thumbs%20in%20this%20patient%20with%20advanced%20rheumatoid%20arthritis.%20Boutonni%C3%A8re%20deformity%20is%20characterized%20by%20flexion%20at%20the%20proximal%20interphalangeal%20joint%20and%20hyperextension%20at%20the%20distal%20interphalangeal%20joint.%20There%20also%20are%20multiple%20rheumatoid%20nodules%20over%20the%20knuckles%20and%20interphalangeal%20joints.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/b/o/u/boutonniere_deformity_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/o/u/boutonniere_deformity_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v28489898","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"698","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Boutonni%C3%A8re%20Deformity%20in%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Ulnar Deviation">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/u/l/n/ulnar_deviation_high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="892" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Ulnar Deviation
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Ulnar Deviation","Credits":"\u003cspan id=\u0022v85663451\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eBy permission of the publisher. From Mabrey J: \u003cspan data-mmanualobjecttype=\u0022pubtitle\u0022\u003eCurrent Orthopedic Diagnosis and Treatment\u003c/span\u003e. Edited by JD Heckman, RC Schenck, and A Agarwal. Philadelphia, Current Medicine, 2002. \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"0d3b93f6-280d-4c6d-87fb-73db1f57c5b6","Title":"Ulnar%20Deviation","ShareUrlTitle":"ulnar-deviation","Description":"%3Cp%3EThis%20image%20of%20a%20patient%20with%20long-standing%20rheumatoid%20arthritis%20shows%20synovitis%20of%20the%20metacarpophalangeal%20joints%20with%20an%20ulnar%20drift%20of%20the%20digits.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/u/l/n/ulnar_deviation_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/u/l/n/ulnar_deviation_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v29656888","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"892","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Ulnar%20Deviation","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Boutonnière and swan-neck deformities">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/m/u/s/mus_boutonniere.gif?mw=350&amp;thn=0&amp;sc_lang=en" width="415" height="200" loading="lazy">
 </div>
 <span class="hero__description">
 Boutonnière and swan-neck...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Boutonnière and swan-neck deformities","Credits":"","IsRestricted":false,"ItemId":"92555501-a536-49bb-8153-55e057fbbca4","Title":"Boutonni%C3%A8re%20and%20swan-neck%20deformities","ShareUrlTitle":"boutonnière-and-swan-neck-deformities","Description":"","ImageUrl":"./~/media/manual/professional/images/m/u/s/mus_boutonniere.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/m/u/s/mus_boutonniere.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"MUS_boutonniere.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"415","ImageHeight":"200","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Boutonni%C3%A8re%20and%20swan-neck%20deformities","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Cervical Spine Involvement in Rheumatoid Arthritis">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/r/a/a/ra-axial-flexion-extension-combo-yaseen-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="383" loading="lazy">
 </div>
 <span class="hero__description">
 Cervical Spine Involvement...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Cervical Spine Involvement in Rheumatoid Arthritis","Credits":"\u003cspan id=\u0022v85654089\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Kinanah Yaseen, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"d1c4d4ef-f496-479c-ad06-111cbb045057","Title":"Cervical%20Spine%20Involvement%20in%20Rheumatoid%20Arthritis","ShareUrlTitle":"cervical-spine-involvement-in-rheumatoid-arthritis","Description":"%3Cp%3EThese%20flexion%20and%20extension%20x-rays%20of%20the%20cervical%20spine%20show%20widening%20of%20the%20atlantoaxial%20distance%20measuring%20up%20to%205%20mm%20on%20the%20flexion%20view%2C%20which%20reduces%20with%20extension.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/r/a/a/ra-axial-flexion-extension-combo-yaseen-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/r/a/a/ra-axial-flexion-extension-combo-yaseen-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v73979930","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"383","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Cervical%20Spine%20Involvement%20in%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Rheumatoid Nodules (Ulna)">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/r/h/e/rheumatoid_nodules_arrow_high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="660" loading="lazy">
 </div>
 <span class="hero__description">
 Rheumatoid Nodules (Ulna)
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Rheumatoid Nodules (Ulna)","Credits":"\u003cspan id=\u0022v85661536\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eBy permission of the publisher. From Matteson E, Mason T: \u003cspan data-mmanualobjecttype=\u0022pubtitle\u0022\u003eAtlas of Rheumatology\u003c/span\u003e. Edited by G Hunder. Philadelphia, Current Medicine, 2005. \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"953475fb-c888-42bc-9b5f-f7cb4b4b84f2","Title":"Rheumatoid%20Nodules%20%28Ulna%29","ShareUrlTitle":"rheumatoid-nodules-ulna","Description":"%3Cp%3ESubcutaneous%20rheumatoid%20nodules%20%28arrow%29%20commonly%20form%20over%20pressure%20points%20as%20in%20this%20patient%20with%20olecranon%20bursitis.%20The%20nodules%20may%20be%20within%20subcutaneous%20tissue%20overlying%20the%20bursae%20or%20may%20be%20subperiosteal%20to%20the%20extensor%20surface%20of%20the%20ulna.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/r/h/e/rheumatoid_nodules_arrow_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/r/h/e/rheumatoid_nodules_arrow_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v29656902","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"660","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Rheumatoid%20Nodules%20%28Ulna%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Rheumatoid Nodules (Foot)">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/c/0/0/c0085678-rheumatoid-nodules-feet-science-photo-library-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="664" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Rheumatoid Nodules (Foot)
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Rheumatoid Nodules (Foot)","Credits":"\u003cspan id=\u0022v85661528\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eDR P. MARAZZI/SCIENCE PHOTO LIBRARY \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"1805632d-47df-4417-98bf-3817f4b9aacf","Title":"Rheumatoid%20Nodules%20%28Foot%29","ShareUrlTitle":"rheumatoid-nodules-foot","Description":"%3Cp%3EThis%20photo%20shows%20rheumatoid%20nodules%20on%20the%20sole%20of%20the%20foot%20in%20a%20patient%20with%20rheumatoid%20arthritis.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/0/c0085678-rheumatoid-nodules-feet-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/0/c0085678-rheumatoid-nodules-feet-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34377279","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"664","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Rheumatoid%20Nodules%20%28Foot%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Rheumatoid Nodule (Hand)">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/c/0/1/c0111770-rheumatoid-nodule-hand-science-photo-library-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="665" loading="lazy">
 </div>
 <span class="hero__description">
 Rheumatoid Nodule (Hand)
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Rheumatoid Nodule (Hand)","Credits":"\u003cspan id=\u0022v85661520\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eDR P. MARAZZI/SCIENCE PHOTO LIBRARY \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"99870330-9b95-4eba-a157-2f2609a268a4","Title":"Rheumatoid%20Nodule%20%28Hand%29","ShareUrlTitle":"rheumatoid-nodule-hand","Description":"%3Cp%3EThis%20photo%20shows%20a%20rheumatoid%20nodule%20over%20the%20metacarpal%20joint%20of%20a%20patient%20with%20rheumatoid%20arthritis.%20%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/1/c0111770-rheumatoid-nodule-hand-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/1/c0111770-rheumatoid-nodule-hand-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34377299","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"665","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Rheumatoid%20Nodule%20%28Hand%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="X-Ray Features of Early Rheumatoid Arthritis">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/x/r/a/xray_early_ra_high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="765" loading="lazy">
 </div>
 <span class="hero__description">
 X-Ray Features of Early Rheumatoi...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"X-Ray Features of Early Rheumatoid Arthritis","Credits":"\u003cspan id=\u0022v85663974\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eBy permission of the publisher. From Matteson E, Mason T: \u003cspan data-mmanualobjecttype=\u0022pubtitle\u0022\u003eAtlas of Rheumatology\u003c/span\u003e. Edited by G Hunder. Philadelphia, Current Medicine, 2005. \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"f03d6486-4203-480b-bac2-76cc22220a24","Title":"X-Ray%20Features%20of%20Early%20Rheumatoid%20Arthritis","ShareUrlTitle":"x-ray-features-of-early-rheumatoid-arthritis","Description":"%3Cp%3EFeatures%20of%20aggressive%2C%20early%20rheumatoid%20arthritis%2C%20as%20seen%20in%20this%20x-ray%20of%20a%2061-year-old%20woman%20with%20rheumatoid%20arthritis%20for%201%20year%2C%20include%20evidence%20of%20soft-tissue%20swelling%20of%20the%20metacarpophalangeal%20and%20proximal%20interphalangeal%20joints%2C%20periarticular%20osteoporosis%2C%20symmetric%20joint%20space%20narrowing%20of%20several%20metacarpophalangeal%20and%20proximal%20interphalangeal%20joints%20of%20both%20hands%2C%20and%20subtle%20erosions%20of%20the%20right%203rd%20and%20right%20and%20left%204th%20metacarpophalangeal%20joints.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/x/r/a/xray_early_ra_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/x/r/a/xray_early_ra_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v29656909","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"765","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"X-Ray%20Features%20of%20Early%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (3)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Classification Criteria for Rheumatoid Arthritis">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Classification Criteria for...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"ca16c8da-1fd0-4466-b7d4-8c027424b314","Title":"Classification%20Criteria%20for%20Rheumatoid%20Arthritis","ShareUrlTitle":"classification-criteria-for-rheumatoid-arthritis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v29657258","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Classification%20Criteria%20for%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Nonsteroidal Anti-inflammatory Drug (NSAID) Treatment of Rheumatoid Arthritis">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Nonsteroidal Anti-inflammatory...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"2827eb2d-16ab-4791-930e-ba248e2049c8","Title":"Nonsteroidal%20Anti-inflammatory%20Drug%20%28NSAID%29%20Treatment%20of%20Rheumatoid%20Arthritis","ShareUrlTitle":"nonsteroidal-anti-inflammatory-drug-nsaid-treatment-of-rheumatoid-arthritis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v29657517","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Nonsteroidal%20Anti-inflammatory%20Drug%20%28NSAID%29%20Treatment%20of%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Other Drugs Used to Treat Rheumatoid Arthritis">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Other Drugs Used to Treat...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"b2c02bc3-78f8-4684-806c-c1fd170b790b","Title":"Other%20Drugs%20Used%20to%20Treat%20Rheumatoid%20Arthritis","ShareUrlTitle":"other-drugs-used-to-treat-rheumatoid-arthritis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v29657694","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Other%20Drugs%20Used%20to%20Treat%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v29657166" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases. Characteristically, peripheral joints (eg, wrists, metacarpophalangeal joints) are symmetrically inflamed, leading to progressive destruction of articular structures, usually accompanied by systemic symptoms. Diagnosis is based on specific clinical, laboratory, and imaging features. Treatment involves drugs, physical measures, and sometimes surgery. Disease-modifying antirheumatic drugs can reduce symptoms and slow disease progression.</div></p></div><span id="v29657168" class="anchor"></span><div class="para"> <p>Rheumatoid arthritis affects about 1% of the population. Women are affected 2 to 3 times more often than men. Onset may be at any age, most often between 35 years and 50 years, but can be during childhood (see <a href="./{A44484CA-4C5B-470B-BBDB-88B0DCD21FBB}.html" data-toggle="tooltip" title="Juvenile Idiopathic Arthritis (JIA)" data-id="f8459f2b-1f5f-4cc2-a7aa-dcc714ee8fc2" data-itemid="a44484ca-4c5b-470b-bbdb-88b0dcd21fbb">Juvenile Idiopathic Arthritis</a><span id="f8459f2b-1f5f-4cc2-a7aa-dcc714ee8fc2" class="d-none xref"> <span class="tooltip-container"> <a href="./{A44484CA-4C5B-470B-BBDB-88B0DCD21FBB}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Juvenile Idiopathic Arthritis (JIA) </span> Juvenile idiopathic arthritis is a group of rheumatic diseases that begins by age 16. Arthritis, fever, rash, adenopathy, splenomegaly, and iridocyclitis are typical of some forms. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/1/c0139735-psoriasis-of-fingernail-spl-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Juvenile Idiopathic Arthritis (JIA)" loading="lazy"> </span> </a> </span> </span>) or old age.</p></div> <section id="v29657170" class="topic__section FHead" itemprop="cause" itemscope="" itemtype="http://schema.org/MedicalCause"> <h2 id="Etiology_v29657171" class="topic__header--section" data-originaltitle="Etiology"> <span id="v29657171" class="anchor"></span> Etiology of Rheumatoid Arthritis </h2> <div class="topic__content"> <span id="v29657172" class="anchor"></span><div class="para"> <p>Although rheumatoid arthritis involves autoimmune reactions, the precise cause is unknown; many factors may contribute. A genetic predisposition has been identified and, in White populations, localized to a shared epitope in the HLA-DRB1 locus of class II histocompatibility antigens. Unknown or unconfirmed environmental factors (eg, viral infections, cigarette smoking) are thought to play a role in triggering and maintaining joint inflammation.</p></div><span id="v73980592" class="anchor"></span><div class="para"> <p>Risk factors for rheumatoid arthritis include the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v73980595" class="anchor"></span><div class="para"> <p>Smoking</p></div></li><li class="topic__listitem"><span id="v73980597" class="anchor"></span><div class="para"> <p>Obesity</p></div></li><li class="topic__listitem"><span id="v73980599" class="anchor"></span><div class="para"> <p>Sex hormones</p></div></li><li class="topic__listitem"><span id="v73980601" class="anchor"></span><div class="para"> <p>Drugs</p></div></li><li class="topic__listitem"><span id="v73980603" class="anchor"></span><div class="para"> <p>Changes in microbiome of the gut, mouth, and lung (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v73980610" data-toggle="tooltip" title="Etiology references" data-id="bf5e7dde-135f-4b72-a81a-a35daf247d29" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">1</a><span id="bf5e7dde-135f-4b72-a81a-a35daf247d29" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v73980610"> <span class="tooltip-content"> <span class="tooltip-heading"> Etiology references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Etiology references" loading="lazy"> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v73980606" class="anchor"></span><div class="para"> <p>Periodontal disease (<a href="./{4B65F037-1E16-4907-969A-B178428DF0B2}.html" data-toggle="tooltip" title="Periodontitis" data-id="7b914749-4528-489f-ba40-2b401f4d5545" data-itemid="4b65f037-1e16-4907-969a-b178428df0b2">periodontitis</a><span id="7b914749-4528-489f-ba40-2b401f4d5545" class="d-none xref"> <span class="tooltip-container"> <a href="./{4B65F037-1E16-4907-969A-B178428DF0B2}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Periodontitis </span> Periodontitis is a chronic inflammatory oral disease that progressively destroys the tooth-supporting apparatus. It usually manifests as a worsening of gingivitis and then, if untreated, with... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0237582-periodontitis-receding-gums-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Periodontitis" loading="lazy"> </span> </a> </span> </span>) (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v73980610" data-toggle="tooltip" title="Etiology references" data-id="e8043ed7-b1cc-4b61-a252-be4ffc352980" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">2</a><span id="e8043ed7-b1cc-4b61-a252-be4ffc352980" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v73980610"> <span class="tooltip-content"> <span class="tooltip-heading"> Etiology references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Etiology references" loading="lazy"> </span> </a> </span> </span>)</p></div></li></ul></div> <section id="v73980609" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalCause"></span> <h3 id="Etiology_v29657171_v73980610" class="topic__header--subsection"> <span itemprop="name" id="v73980610" class="anchor"></span> Etiology references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v73980613" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744513/">Block KE, Zheng Z, Dent AL, et al</a>: Gut microbiota regulates K/BxN autoimmune arthritis through follicular helper T but not Th17 cells. <i>J Immunol</i> 196(4):1550-7, 2016. doi: 10.4049/jimmunol.1501904</p></div></li><li class="topic__listitem"><span id="v73980616" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941529/">Wegner N, Wait R, Sroka A, et al</a>: Peptidylarginine deiminase from <i>Porphyromonas gingivalis</i> citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. <i>Arthritis Rheum</i> 62(9):2662-72, 2010. doi: 10.1002/art.27552</p></div></li></ul></div> </div> </section> </div> </section> <section id="v29657173" class="topic__section FHead"> <h2 id="Pathophysiology_v29657174" class="topic__header--section" data-originaltitle="Pathophysiology"> <span id="v29657174" class="anchor"></span> Pathophysiology of Rheumatoid Arthritis </h2> <div class="topic__content"> <span id="v29657175" class="anchor"></span><div class="para"> <p>Prominent immunologic abnormalities include immune complexes produced by synovial lining cells and in inflamed blood vessels. Plasma cells produce antibodies (eg, rheumatoid factor [RF], anticyclic citrullinated peptide [anti-CCP] antibody) that contribute to these complexes, but destructive arthritis can occur in their absence. Macrophages also migrate to diseased synovium in early disease; increased macrophage-derived lining cells are prominent along with vessel inflammation. Lymphocytes that infiltrate the synovial tissue are primarily CD4<span class='symbol'>+</span> T cells. Macrophages and lymphocytes produce pro-inflammatory cytokines and chemokines (eg, tumor necrosis factor [TNF]-alpha, granulocyte-macrophage colony-stimulating factor [GM-CSF], various interleukins, interferon-gamma) in the synovium. Released inflammatory mediators and various enzymes contribute to the systemic and joint manifestations of rheumatoid arthritis, including cartilage and bone destruction (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657183" data-toggle="tooltip" title="Pathophysiology references" data-id="3fefac9f-45c7-4737-afd4-aa7fd347d3bc" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">1</a><span id="3fefac9f-45c7-4737-afd4-aa7fd347d3bc" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657183"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v29657176" class="anchor"></span><div class="para"> <p>In seropositive rheumatoid arthritis, accumulating evidence suggests that anti-CCP antibodies appear long before any signs of inflammation (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657183" data-toggle="tooltip" title="Pathophysiology references" data-id="1c45e7ac-8d57-4b05-80a0-59f981e2372a" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">2</a><span id="1c45e7ac-8d57-4b05-80a0-59f981e2372a" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657183"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology references" loading="lazy"> </span> </a> </span> </span>). Additionally, anti-carbamylated protein (anti-CarP) antibodies (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657183" data-toggle="tooltip" title="Pathophysiology references" data-id="6a649229-f4e2-431e-912c-8ff87f0265ef" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">3</a><span id="6a649229-f4e2-431e-912c-8ff87f0265ef" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657183"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology references" loading="lazy"> </span> </a> </span> </span>) predict more radiologic progression in anti-CCP–negative rheumatoid arthritis patients. Progression to rheumatoid arthritis in the preclinical phase depends on autoantibody epitope spreading in which there are immune responses to released self-antigens with subsequent increased inflammation (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657183" data-toggle="tooltip" title="Pathophysiology references" data-id="c41a1759-afc1-485a-826a-e09a8be361b5" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">4</a><span id="c41a1759-afc1-485a-826a-e09a8be361b5" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657183"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v29657180" class="anchor"></span><div class="para"> <p>In chronically affected joints, the normally thin synovium proliferates, thickens, and develops many villous folds. The synovial lining cells produce various materials, including <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>collagenase</span> and stromelysin, which contribute to cartilage destruction, and interleukin-1 (IL-1) and TNF-alpha, which stimulate cartilage destruction, osteoclast-mediated bone absorption, synovial inflammation, and prostaglandins (which potentiate inflammation). Fibrin deposition, fibrosis, and necrosis are also present. Hyperplastic synovial tissue (pannus) releases these inflammatory mediators, which erode cartilage, subchondral bone, articular capsule, and ligaments. Polymorphonuclear leukocytes on average make up about 60% of white blood cells in the synovial fluid.</p></div><span id="v29657181" class="anchor"></span><div class="para"> <p>Rheumatoid nodules develop in about 30% of patients with rheumatoid arthritis. They are granulomas consisting of a central necrotic area surrounded by palisaded histiocytic macrophages, all enveloped by lymphocytes, plasma cells, and fibroblasts. Nodules can also develop in visceral organs.</p></div> <section id="v29657182" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v29657174_v29657183" class="topic__header--subsection"> <span id="v29657183" class="anchor"></span> Pathophysiology references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v48477166" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/22150039/">McInnes IB, Schett G</a>: The pathogenesis of rheumatoid arthritis.<i> N Engl J Med</i> 365(23):2205–2219, 2011. doi:10.1056/NEJMra1004965</p></div></li><li class="topic__listitem"><span id="v29657186" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1002/art.11223/abstract;jsessionid=40D3D442EA508615BEC80B00FD963057.f02t02">Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al</a>: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. <i>Arthritis Rheum</i> 48:2741–2749, 2003. doi: 10.1002/art.11223</p></div></li><li class="topic__listitem"><span id="v29657189" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-015-0536-2">Brink M, Verheul MK, Rönnelid J, et al</a>: Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage. <i>Arthritis Res Ther</i> 17:25, 2015. doi: 10.1186/s13075-015-0536-2</p></div></li><li class="topic__listitem"><span id="v29657192" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035296">Sokolove J, Bromberg R, Deane KD, et al</a>: Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. <i>PLoS ONE</i> 7(5):e35296, 2012. doi: 10.1371/journal.pone.0035296</p></div></li></ul></div> </div> </section> </div> </section> <section id="v29657195" class="topic__section FHead" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <h2 id="SymptomsAndSigns_v29657196" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v29657196" class="anchor"></span> Symptoms and Signs of Rheumatoid Arthritis </h2> <div class="topic__content"> <span id="v29657197" class="anchor"></span><div class="para"> <p>Onset of rheumatoid arthritis is usually insidious, often beginning with systemic and joint symptoms. Systemic symptoms include generalized afternoon fatigue and malaise, anorexia, generalized weakness, and occasionally low-grade fever. Joint symptoms include pain, swelling, and stiffness. Occasionally, the disease begins abruptly, mimicking an acute viral syndrome.</p></div><span id="v29657198" class="anchor"></span><div class="para"> <p>The disease progresses most rapidly during the first 6 years, particularly the first year; 80% of patients develop some permanent joint abnormalities within 10 years. The course is unpredictable in individual patients.</p></div><span id="v29657199" class="anchor"></span><div class="para"> <p>Joint symptoms are characteristically symmetric. Typically, stiffness lasts <span class='symbol'>></span> 60 minutes after rising in the morning but may occur after any prolonged inactivity (called gelling). Involved joints become tender, with erythema, warmth, swelling, and limitation of motion. The joints primarily involved include the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657202" class="anchor"></span><div class="para"> <p>Wrists and the index (2nd) and middle (3rd) metacarpophalangeal joints (most commonly involved)</p></div></li><li class="topic__listitem"><span id="v29657204" class="anchor"></span><div class="para"> <p>Proximal interphalangeal joints</p></div></li><li class="topic__listitem"><span id="v29657206" class="anchor"></span><div class="para"> <p>Metatarsophalangeal joint</p></div></li><li class="topic__listitem"><span id="v29657208" class="anchor"></span><div class="para"> <p>Shoulders</p></div></li><li class="topic__listitem"><span id="v29657210" class="anchor"></span><div class="para"> <p>Elbows</p></div></li><li class="topic__listitem"><span id="v29657212" class="anchor"></span><div class="para"> <p>Hips</p></div></li><li class="topic__listitem"><span id="v29657214" class="anchor"></span><div class="para"> <p>Knees</p></div></li><li class="topic__listitem"><span id="v29657216" class="anchor"></span><div class="para"> <p>Ankles</p></div></li></ul></div><span id="v29657217" class="anchor"></span><div class="para"> <p>However, virtually any joint, except the distal interphalangeal (DIP) joints, may be involved. Initial manifestations include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v73980620" class="anchor"></span><div class="para"> <p>Monoarthritis of knee, wrist, shoulder, or ankle</p></div></li><li class="topic__listitem"><span id="v73980622" class="anchor"></span><div class="para"> <p>Polymyalgia rheumatica–like presentation predominantly with shoulder and hip girdle involvement, especially in older patients</p></div></li><li class="topic__listitem"><span id="v73980624" class="anchor"></span><div class="para"> <p>Palindromic rheumatism, characterized by recurrent attacks of joint and tendon sheath pain with swelling</p></div></li><li class="topic__listitem"><span id="v73980626" class="anchor"></span><div class="para"> <p>Joint swelling without chronic joint damage</p></div></li><li class="topic__listitem"><span id="v73980628" class="anchor"></span><div class="para"> <p>Robustus rheumatoid arthritis with proliferative synovitis but minimal pain</p></div></li></ul></div><span id="v73980629" class="anchor"></span><div class="para"> <p>Lower spine involvement is not characteristic of rheumatoid arthritis, but cervical spine inflammation can result in instability, which can become an emergency. Synovial thickening and swelling are often detectable. Joints are often held in flexion to minimize pain, which results from joint capsular distention.</p></div><span id="v29657218" class="anchor"></span><div class="para"> <p>Fixed deformities, particularly flexion contractures, may develop rapidly; ulnar deviation of the fingers with an ulnar slippage of the extensor tendons off the metacarpophalangeal joints is typical, as are <a href="./{7EB6E7C6-7A5C-4F48-A6A8-53198D8B0B08}.html" data-toggle="tooltip" title="Swan-Neck Deformity" data-id="3e79a630-e9b6-4d97-88cd-4d99346a72ca" data-itemid="7eb6e7c6-7a5c-4f48-a6a8-53198d8b0b08">swan-neck deformities</a><span id="3e79a630-e9b6-4d97-88cd-4d99346a72ca" class="d-none xref"> <span class="tooltip-container"> <a href="./{7EB6E7C6-7A5C-4F48-A6A8-53198D8B0B08}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Swan-Neck Deformity </span> A swan-neck deformity consists of hyperextension of the proximal interphalangeal (PIP) joint, flexion of the distal interphalangeal (DIP) joint, and sometimes flexion of the metacarpophalangeal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Swan-Neck Deformity" loading="lazy"> </span> </a> </span> </span> and <a href="./{7EDA3E07-BDAF-483A-A95C-BE0138DDF7D3}.html" data-toggle="tooltip" title="Boutonnière Deformity" data-id="9766c6cb-4695-4586-a9bc-7b0fc8892ae1" data-itemid="7eda3e07-bdaf-483a-a95c-be0138ddf7d3">boutonnière deformities</a><span id="9766c6cb-4695-4586-a9bc-7b0fc8892ae1" class="d-none xref"> <span class="tooltip-container"> <a href="./{7EDA3E07-BDAF-483A-A95C-BE0138DDF7D3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Boutonnière Deformity </span> A boutonnière deformity consists of flexion of the proximal interphalangeal (PIP) joint accompanied by hyperextension of the distal interphalangeal (DIP) joint. (See also Overview and Evaluation... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/b/o/u/boutonniere_deformity_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Boutonnière Deformity" loading="lazy"> </span> </a> </span> </span>. Joint instability due to stretching of the joint capsule can also occur. <a href="./{638B4375-44B5-46CA-A787-927CD132AE26}.html" data-toggle="tooltip" title="Carpal Tunnel Syndrome" data-id="c586d264-2a74-488b-8dfe-69850342ef7d" data-itemid="638b4375-44b5-46ca-a787-927cd132ae26">Carpal tunnel syndrome</a><span id="c586d264-2a74-488b-8dfe-69850342ef7d" class="d-none xref"> <span class="tooltip-container"> <a href="./{638B4375-44B5-46CA-A787-927CD132AE26}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Carpal Tunnel Syndrome </span> Carpal tunnel syndrome is compression of the median nerve as it passes through the carpal tunnel in the wrist. Symptoms include pain and paresthesias in the median nerve distribution. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/a/r/carpal-tunnel-syndrome-pv-only-blausen-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Carpal Tunnel Syndrome" loading="lazy"> </span> </a> </span> </span> can result from wrist synovitis compressing the median nerve. <a href="./{3510407E-AC9E-4C40-AC42-1B6E5554C028}.html" data-toggle="tooltip" title="Baker Cysts" data-id="59d4a410-d698-406f-8361-b4fce16d57da" data-itemid="3510407e-ac9e-4c40-ac42-1b6e5554c028">Popliteal (Baker) cysts</a><span id="59d4a410-d698-406f-8361-b4fce16d57da" class="d-none xref"> <span class="tooltip-container"> <a href="./{3510407E-AC9E-4C40-AC42-1B6E5554C028}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Baker Cysts </span> Baker cysts are enlarged bursae in the popliteal fossa. They are filled with synovial fluid and usually communicate with the adjacent joint space. Symptoms include pain, swelling behind the... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> can develop, causing calf swelling and tenderness suggestive of deep venous thrombosis.</p></div><span id="v73980631" class="anchor"></span><div class="para"> <p>Cervical spine involvement is common in longstanding active disease and usually presents as pain and stiffness, sometimes with radicular pain or features of myelopathy with hyperreflexia and occipital headache. </p></div><span id="v73980632" class="anchor"></span><div class="para"> <p>Cricoarytenoid joint arthritis can manifest as voice hoarseness and respiratory stridor.</p></div> <div class="inlinebox__clear"></div> <div class="inlinemedia inlinemedia--full inlinemedia--slider" data-slide-count="3"> <div class="inlinemedia__wrapper"> <div class="inlinemedia__header"> <div class="inlinemedia__title">Examples of Fixed Deformities</div> <div class="inlinemedia__open"> <i class="inlinemedia__icon--open"></i> </div> </div> <div class="tablebox inlinemedia__container"> <div class="tablebox__cell slidernav__previous" role="button" tabindex="0" aria-label="Previous"></div> <div class="tablebox__cell inlinemedia__content"> <div class="inlinemedia__slides"> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?mw=350&thn=0&sc_lang=en" alt="Swan-Neck" deformity="" loading="lazy" width="664" height="1000"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Swan-Neck Deformity","Credits":"\u003cspan id=\u0022v85662714\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eSCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"aca2f9e8-9ebe-4588-8f1a-a4318c591b86","Title":"Swan-Neck%20Deformity","ShareUrlTitle":"swan-neck-deformity","Description":"%3Cp%3ESwan%20neck%20deformity%20is%20characterized%20by%20extension%20at%20proximal%20interphalangeal%20joint%20and%20flexion%20at%20distal%20interphalangeal%20joint.%20%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v29656882","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"664","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v48612713","LinkText":"Swan-Neck%20Deformity","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Examples%20of%20Fixed%20Deformities","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Swan-Neck Deformity</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88810740" class="anchor"></span><div class="para"> <p>Swan neck deformity is characterized by extension at proximal interphalangeal joint and flexion at distal interphalangeal joint. </p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85662714" class="anchor"></span><div class="para"> <p>SCIENCE PHOTO LIBRARY</p></div></figcaption> </figure> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/b/o/u/boutonniere_deformity_high.jpg?mw=350&thn=0&sc_lang=en" alt="Boutonnière" deformity="" in="" rheumatoid="" arthritis="" loading="lazy" width="1000" height="698"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Boutonnière Deformity in Rheumatoid Arthritis","Credits":"\u003cspan id=\u0022v85653634\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eBy permission of the publisher. From Matteson E, Mason T: Atlas of Rheumatology. Edited by G Hunder. Philadelphia, Current Medicine, 2005.\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"095e8740-1a42-4b39-b531-4e0167ddece9","Title":"Boutonni%C3%A8re%20Deformity%20in%20Rheumatoid%20Arthritis","ShareUrlTitle":"boutonnière-deformity-in-rheumatoid-arthritis","Description":"%3Cp%3EThere%20are%20multiple%20boutonni%C3%A8re%20deformities%20of%20the%20fingers%20and%20thumbs%20in%20this%20patient%20with%20advanced%20rheumatoid%20arthritis.%20Boutonni%C3%A8re%20deformity%20is%20characterized%20by%20flexion%20at%20the%20proximal%20interphalangeal%20joint%20and%20hyperextension%20at%20the%20distal%20interphalangeal%20joint.%20There%20also%20are%20multiple%20rheumatoid%20nodules%20over%20the%20knuckles%20and%20interphalangeal%20joints.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/b/o/u/boutonniere_deformity_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/o/u/boutonniere_deformity_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v28489898","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"698","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v48612713","LinkText":"Boutonni%C3%A8re%20Deformity%20in%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Examples%20of%20Fixed%20Deformities","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Boutonnière Deformity in Rheumatoid Arthritis</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88810742" class="anchor"></span><div class="para"> <p>There are multiple boutonnière deformities of the fingers and thumbs in this patient with advanced rheumatoid arthritis. Boutonnière deformity is characterized by flexion at the proximal interphalangeal joint and hyperextension at the distal interphalangeal joint. There also are multiple rheumatoid nodules over the knuckles and interphalangeal joints.</p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85653634" class="anchor"></span><div class="para"> <p>By permission of the publisher. From Matteson E, Mason T: Atlas of Rheumatology. Edited by G Hunder. Philadelphia, Current Medicine, 2005.</p></div></figcaption> </figure> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/u/l/n/ulnar_deviation_high.jpg?mw=350&thn=0&sc_lang=en" alt="Ulnar" deviation="" loading="lazy" width="892" height="1000"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Ulnar Deviation","Credits":"\u003cspan id=\u0022v85663451\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eBy permission of the publisher. From Mabrey J: \u003cspan data-mmanualobjecttype=\u0022pubtitle\u0022\u003eCurrent Orthopedic Diagnosis and Treatment\u003c/span\u003e. Edited by JD Heckman, RC Schenck, and A Agarwal. Philadelphia, Current Medicine, 2002. \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"0d3b93f6-280d-4c6d-87fb-73db1f57c5b6","Title":"Ulnar%20Deviation","ShareUrlTitle":"ulnar-deviation","Description":"%3Cp%3EThis%20image%20of%20a%20patient%20with%20long-standing%20rheumatoid%20arthritis%20shows%20synovitis%20of%20the%20metacarpophalangeal%20joints%20with%20an%20ulnar%20drift%20of%20the%20digits.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/u/l/n/ulnar_deviation_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/u/l/n/ulnar_deviation_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v29656888","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"892","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v48612713","LinkText":"Ulnar%20Deviation","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Examples%20of%20Fixed%20Deformities","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Ulnar Deviation</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88810744" class="anchor"></span><div class="para"> <p>This image of a patient with long-standing rheumatoid arthritis shows synovitis of the metacarpophalangeal joints with an ulnar drift of the digits.</p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85663451" class="anchor"></span><div class="para"> <p>By permission of the publisher. From Mabrey J: <span data-mmanualobjecttype="pubtitle">Current Orthopedic Diagnosis and Treatment</span>. Edited by JD Heckman, RC Schenck, and A Agarwal. Philadelphia, Current Medicine, 2002. </p></div></figcaption> </figure> </div> </div> <div class="tablebox__cell slidernav__next" role="button" tabindex="0" aria-label="Next"></div> </div> <div class="tablebox slidernav__dots"> <div class="tablebox__cell slidernav__fill"></div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="0" tabindex="0" role="button" aria-label="Indicator 0"></div> </div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="1" tabindex="0" role="button" aria-label="Indicator 1"></div> </div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="2" tabindex="0" role="button" aria-label="Indicator 2"></div> </div> <div class="tablebox__cell slidernav__fill"></div> </div> </div> </div> <span id="v29657222"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--figure "> <div class="inlinebox__wrapper"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v29657224"></span> <div class="FigureFullPage" id="v29657223"> <h3 class="title">Boutonnière and swan-neck deformities</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td> <div class="inlinemedia__container"> <div class="inlinemedia__image--container"> <img oncontextmenu="return false;" data-mmanualobjecttype="Image" src="./~/media/manual/professional/images/m/u/s/mus_boutonniere.gif?thn=0&sc_lang=en" alt="Boutonnière and swan-neck deformities" lang="" loading="lazy" height="200" width="415"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Boutonnière and swan-neck deformities","Credits":"","IsRestricted":false,"ItemId":"92555501-a536-49bb-8153-55e057fbbca4","Title":"Boutonni%C3%A8re%20and%20swan-neck%20deformities","ShareUrlTitle":"boutonnière-and-swan-neck-deformities","Description":"","ImageUrl":"./~/media/manual/professional/images/m/u/s/mus_boutonniere.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/m/u/s/mus_boutonniere.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"MUS_boutonniere.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"415","ImageHeight":"200","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"","LinkText":"Boutonni%C3%A8re%20and%20swan-neck%20deformities","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":true,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> </div> </div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: Figure --> </div> <section id="v29657234" class="topic__section GHead"> <span></span> <h3 id="SymptomsAndSigns_v29657196_v29657235" class="topic__header--subsection"> <span id="v29657235" class="anchor"></span> Extra-articular manifestations </h3> <div class="topic__content"> <span id="v29657237" class="anchor"></span><div class="para"> <p><b>Subcutaneous rheumatoid nodules</b> are not usually an early sign but eventually develop in up to 30% of patients, usually at sites of pressure and chronic irritation (eg, the extensor surface of the forearm, metacarpophalangeal joints, soles of feet). Paradoxically, rheumatoid nodules can increase in patients taking <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span>, despite lessening of joint inflammation. Visceral nodules (eg, pulmonary) are usually asymptomatic and may occur in severe rheumatoid arthritis. Pulmonary nodules of rheumatoid arthritis cannot be distinguished from pulmonary nodules of other etiology without biopsy. </p></div><span id="v29657238" class="anchor"></span><div class="para"> <p>Other extra-articular signs include <a href="./{D24AA14D-9999-43AD-AE58-6160C20031E0}.html" data-toggle="tooltip" title="Cutaneous Vasculitis" data-id="a619f825-e5f6-4f61-9c1e-6ccee6da2204" data-itemid="d24aa14d-9999-43ad-ae58-6160c20031e0">vasculitis</a><span id="a619f825-e5f6-4f61-9c1e-6ccee6da2204" class="d-none xref"> <span class="tooltip-container"> <a href="./{D24AA14D-9999-43AD-AE58-6160C20031E0}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Cutaneous Vasculitis </span> Cutaneous vasculitis refers to vasculitis affecting small- or medium-sized vessels in the skin and subcutaneous tissue but not the internal organs. Cutaneous vasculitis may be limited to the... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/9/2/392_vasculitis_slide_42_springer_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Cutaneous Vasculitis" loading="lazy"> </span> </a> </span> </span> causing leg ulcers, digital ischemia, or multiple mononeuropathy (mononeuritis multiplex), pleural or pericardial effusions, obliterative bronchiolitis, <a href="./{D7E23B38-346D-47B9-B2F3-749E8719BF05}.html" data-toggle="tooltip" title="Overview of Interstitial Lung Disease" data-id="801b7ab9-5cb2-4bbd-a855-c0797d59cce4" data-itemid="d7e23b38-346d-47b9-b2f3-749e8719bf05">interstitial lung disease</a><span id="801b7ab9-5cb2-4bbd-a855-c0797d59cce4" class="d-none xref"> <span class="tooltip-container"> <a href="./{D7E23B38-346D-47B9-B2F3-749E8719BF05}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Interstitial Lung Disease </span> Interstitial lung diseases are a heterogeneous group of disorders characterized by alveolar septal thickening, fibroblast proliferation, collagen deposition, and, if the process remains unchecked... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{80FFC91F-3F72-4014-905C-8B4B0BFC3D3A}.html" data-toggle="tooltip" title="Pericarditis" data-id="0d993378-fbf8-4b53-af26-1f94b4e72787" data-itemid="80ffc91f-3f72-4014-905c-8b4b0bfc3d3a">pericarditis</a><span id="0d993378-fbf8-4b53-af26-1f94b4e72787" class="d-none xref"> <span class="tooltip-container"> <a href="./{80FFC91F-3F72-4014-905C-8B4B0BFC3D3A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Pericarditis </span> Pericarditis is inflammation of the pericardium, often with fluid accumulation in the pericardial space. Pericarditis may be caused by many disorders (eg, infection, myocardial infarction, trauma... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/0/c/40-chest-xray-patient-with-pericardial-effusion-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pericarditis" loading="lazy"> </span> </a> </span> </span>, <a href="./{D0B923FA-2931-4757-9C69-56EB40693520}.html" data-toggle="tooltip" title="Myocarditis" data-id="f27a1934-dacf-4235-b8ba-97f78fa0e5ba" data-itemid="d0b923fa-2931-4757-9c69-56eb40693520">myocarditis</a><span id="f27a1934-dacf-4235-b8ba-97f78fa0e5ba" class="d-none xref"> <span class="tooltip-container"> <a href="./{D0B923FA-2931-4757-9C69-56EB40693520}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Myocarditis </span> Myocarditis is inflammation of the myocardium with necrosis of cardiac myocytes. Myocarditis may be caused by many disorders (eg, infection, cardiotoxins, drugs, and systemic disorders such... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/2/m/42-mri-patient-with-myocarditis-and-pericardial-effusion-ctisus-with-arrows.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Myocarditis" loading="lazy"> </span> </a> </span> </span>, <a href="./{571770B3-0D23-42CE-8F60-5F62D0DA780F}.html" data-toggle="tooltip" title="Lymphadenopathy" data-id="17447465-3732-4f51-a9a0-a13d9479765e" data-itemid="571770b3-0d23-42ce-8f60-5f62d0da780f">lymphadenopathy</a><span id="17447465-3732-4f51-a9a0-a13d9479765e" class="d-none xref"> <span class="tooltip-container"> <a href="./{571770B3-0D23-42CE-8F60-5F62D0DA780F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Lymphadenopathy </span> Lymphadenopathy is palpable enlargement of ≥ 1 lymph nodes. Diagnosis is clinical. Treatment is of the causative disorder. (See also Overview of the Lymphatic System.) Lymph nodes are present... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/3/m1310141-non-hodgkin-lymphoma-spl-high-edit.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Lymphadenopathy" loading="lazy"> </span> </a> </span> </span>, Felty syndrome, <a href="./{48A11CFA-DB3D-412E-983B-86AA69EA0F56}.html" data-toggle="tooltip" title="Sjögren Syndrome" data-id="c8cdde88-f287-4a3f-8fc6-03b1ecff010b" data-itemid="48a11cfa-db3d-412e-983b-86aa69ea0f56">Sjögren syndrome</a><span id="c8cdde88-f287-4a3f-8fc6-03b1ecff010b" class="d-none xref"> <span class="tooltip-container"> <a href="./{48A11CFA-DB3D-412E-983B-86AA69EA0F56}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sjögren Syndrome </span> Sjögren syndrome is a relatively common chronic, autoimmune, systemic, inflammatory disorder of unknown cause. It is characterized by dryness of the mouth, eyes, and other mucous membranes ... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/6/m2600013_dry_tongue_in_sjogren_s_syndrome_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Sjögren Syndrome" loading="lazy"> </span> </a> </span> </span>, scleromalacia, and <a href="./{378E7DDA-8543-42EE-A3B4-3E77A0ED9834}.html" data-toggle="tooltip" title="Episcleritis" data-id="9172a896-3409-4379-9236-2592435b478d" data-itemid="378e7dda-8543-42ee-a3b4-3e77a0ed9834">episcleritis</a><span id="9172a896-3409-4379-9236-2592435b478d" class="d-none xref"> <span class="tooltip-container"> <a href="./{378E7DDA-8543-42EE-A3B4-3E77A0ED9834}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Episcleritis </span> Episcleritis is self-limiting, recurring, usually idiopathic inflammation of the episcleral tissue that does not threaten vision. Symptoms are a localized area of hyperemia of the globe, irritation... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/1/c0142766-episcleritis-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Episcleritis" loading="lazy"> </span> </a> </span> </span>.</p></div><span id="v73980635" class="anchor"></span><div class="para"> <p>Involvement of the cervical spine can cause <a href="./{686ECF12-622E-4FE3-9AA5-E6A945A75D3D}.html" data-toggle="tooltip" title="Atlantoaxial Subluxation" data-id="a6194c2a-e945-4107-8760-77fdfd21c5e3" data-itemid="686ecf12-622e-4fe3-9aa5-e6a945a75d3d">atlantoaxial subluxation</a><span id="a6194c2a-e945-4107-8760-77fdfd21c5e3" class="d-none xref"> <span class="tooltip-container"> <a href="./{686ECF12-622E-4FE3-9AA5-E6A945A75D3D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atlantoaxial Subluxation </span> Atlantoaxial subluxation is misalignment of the 1st and 2nd cervical vertebrae, which may occur only with neck flexion. (See also Evaluation of Neck and Back Pain and Craniocervical Junction... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/5/4/5/545-atlantoaxial-subluxation-s139-springer-brighter-blackline-high.gif?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Atlantoaxial Subluxation" loading="lazy"> </span> </a> </span> </span> and <a href="./{D865643F-087F-4144-9FCA-AC1100E72D5F}.html" data-toggle="tooltip" title="Spinal Cord Compression" data-id="32ce2c6f-0ad6-42bb-a77f-5171e8b263ee" data-itemid="d865643f-087f-4144-9fca-ac1100e72d5f">spinal cord compression</a><span id="32ce2c6f-0ad6-42bb-a77f-5171e8b263ee" class="d-none xref"> <span class="tooltip-container"> <a href="./{D865643F-087F-4144-9FCA-AC1100E72D5F}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Spinal Cord Compression </span> Various lesions can compress the spinal cord, causing segmental sensory, motor, reflex, and sphincter deficits. Diagnosis is by MRI. Treatment is directed at relieving compression. (See also... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/p/i/spinal_cord_compression_slide_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Spinal Cord Compression" loading="lazy"> </span> </a> </span> </span>; subluxation may worsen with extension of the neck (eg, during endotracheal intubation). Importantly, cervical spine instability is usually asymptomatic.</p></div> <div class="inlinemedia-component " data-ko-rebind="v73979930" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Cervical Spine Involvement in Rheumatoid Arthritis","Credits":"\u003cspan id=\u0022v85654089\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage courtesy of Kinanah Yaseen, MD.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"d1c4d4ef-f496-479c-ad06-111cbb045057","Title":"Cervical Spine Involvement in Rheumatoid Arthritis","ShareUrlTitle":"cervical-spine-involvement-in-rheumatoid-arthritis","Description":"\u003cul\u003e\u003cspan id=\u0022v88810747\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThese flexion and extension x-rays of the cervical spine show widening of the atlantoaxial distance measuring up to 5 mm on the flexion view, which reduces with extension.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/r/a/a/ra-axial-flexion-extension-combo-yaseen-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/r/a/a/ra-axial-flexion-extension-combo-yaseen-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v73979930","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"383","IframeSrc":null,"Target":null}'> </div><span id="v73980638" class="anchor"></span><div class="para"> <p>Patients with rheumatoid arthritis are at increased risk for early <a href="./{B08A09F4-F747-4FA0-985E-90465F8128C5}.html" data-toggle="tooltip" title="Overview of Coronary Artery Disease" data-id="0253cb61-d998-4bc8-b2d8-028ee7448552" data-itemid="b08a09f4-f747-4fa0-985e-90465f8128c5">coronary artery disease</a><span id="0253cb61-d998-4bc8-b2d8-028ee7448552" class="d-none xref"> <span class="tooltip-container"> <a href="./{B08A09F4-F747-4FA0-985E-90465F8128C5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Coronary Artery Disease </span> Coronary artery disease (CAD) involves impairment of blood flow through the coronary arteries, most commonly by atheromas. Clinical presentations include silent ischemia, angina pectoris, acute... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/a/n/g/angioplasty_stent_01_high_blausen.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Coronary Artery Disease" loading="lazy"> </span> </a> </span> </span>, metabolic bone disease such as osteopenia and <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html" data-toggle="tooltip" title="Osteoporosis" data-id="b404b40d-a0d9-41d8-8e03-780e8d684d6a" data-itemid="d664f6b2-f617-4e76-82f0-06eb947c1f80">osteoporosis</a><span id="b404b40d-a0d9-41d8-8e03-780e8d684d6a" class="d-none xref"> <span class="tooltip-container"> <a href="./{D664F6B2-F617-4E76-82F0-06EB947C1F80}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Osteoporosis </span> Osteoporosis is a progressive metabolic bone disease that decreases bone mineral density (bone mass per unit volume), with deterioration of bone structure. Skeletal weakness leads to fractures... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/d/x/a/dxa-combined-bolster-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Osteoporosis" loading="lazy"> </span> </a> </span> </span>, and various cancers (lung, lymphoproliferative disorders, and nonmelanoma skin cancers), which may be related to underlying, uncontrolled systemic inflammatory processes.</p></div> <div class="inlinebox__clear"></div> <div class="inlinemedia inlinemedia--full inlinemedia--slider" data-slide-count="3"> <div class="inlinemedia__wrapper"> <div class="inlinemedia__header"> <div class="inlinemedia__title">Examples of Rheumatoid Nodule</div> <div class="inlinemedia__open"> <i class="inlinemedia__icon--open"></i> </div> </div> <div class="tablebox inlinemedia__container"> <div class="tablebox__cell slidernav__previous" role="button" tabindex="0" aria-label="Previous"></div> <div class="tablebox__cell inlinemedia__content"> <div class="inlinemedia__slides"> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/r/h/e/rheumatoid_nodules_arrow_high.jpg?mw=350&thn=0&sc_lang=en" alt="Rheumatoid" nodules="" (ulna)="" loading="lazy" width="1000" height="660"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Rheumatoid Nodules (Ulna)","Credits":"\u003cspan id=\u0022v85661536\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eBy permission of the publisher. From Matteson E, Mason T: \u003cspan data-mmanualobjecttype=\u0022pubtitle\u0022\u003eAtlas of Rheumatology\u003c/span\u003e. Edited by G Hunder. Philadelphia, Current Medicine, 2005. \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"953475fb-c888-42bc-9b5f-f7cb4b4b84f2","Title":"Rheumatoid%20Nodules%20%28Ulna%29","ShareUrlTitle":"rheumatoid-nodules-ulna","Description":"%3Cp%3ESubcutaneous%20rheumatoid%20nodules%20%28arrow%29%20commonly%20form%20over%20pressure%20points%20as%20in%20this%20patient%20with%20olecranon%20bursitis.%20The%20nodules%20may%20be%20within%20subcutaneous%20tissue%20overlying%20the%20bursae%20or%20may%20be%20subperiosteal%20to%20the%20extensor%20surface%20of%20the%20ulna.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/r/h/e/rheumatoid_nodules_arrow_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/r/h/e/rheumatoid_nodules_arrow_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v29656902","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"660","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v41326894","LinkText":"Rheumatoid%20Nodules%20%28Ulna%29","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Examples%20of%20Rheumatoid%20Nodule","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Rheumatoid Nodules (Ulna)</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88810749" class="anchor"></span><div class="para"> <p>Subcutaneous rheumatoid nodules (arrow) commonly form over pressure points as in this patient with olecranon bursitis. The nodules may be within subcutaneous tissue overlying the bursae or may be subperiosteal to the extensor surface of the ulna.</p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85661536" class="anchor"></span><div class="para"> <p>By permission of the publisher. From Matteson E, Mason T: <span data-mmanualobjecttype="pubtitle">Atlas of Rheumatology</span>. Edited by G Hunder. Philadelphia, Current Medicine, 2005. </p></div></figcaption> </figure> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/c/0/0/c0085678-rheumatoid-nodules-feet-science-photo-library-high.jpg?mw=350&thn=0&sc_lang=en" alt="Rheumatoid" nodules="" (foot)="" loading="lazy" width="664" height="1000"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Rheumatoid Nodules (Foot)","Credits":"\u003cspan id=\u0022v85661528\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eDR P. MARAZZI/SCIENCE PHOTO LIBRARY \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"1805632d-47df-4417-98bf-3817f4b9aacf","Title":"Rheumatoid%20Nodules%20%28Foot%29","ShareUrlTitle":"rheumatoid-nodules-foot","Description":"%3Cp%3EThis%20photo%20shows%20rheumatoid%20nodules%20on%20the%20sole%20of%20the%20foot%20in%20a%20patient%20with%20rheumatoid%20arthritis.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/0/c0085678-rheumatoid-nodules-feet-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/0/c0085678-rheumatoid-nodules-feet-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34377279","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"664","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v41326894","LinkText":"Rheumatoid%20Nodules%20%28Foot%29","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Examples%20of%20Rheumatoid%20Nodule","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Rheumatoid Nodules (Foot)</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88810751" class="anchor"></span><div class="para"> <p>This photo shows rheumatoid nodules on the sole of the foot in a patient with rheumatoid arthritis.</p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85661528" class="anchor"></span><div class="para"> <p>DR P. MARAZZI/SCIENCE PHOTO LIBRARY </p></div></figcaption> </figure> <figure class="inlinemedia__figure js-carousel-slide"> <img src="./~/media/manual/professional/images/c/0/1/c0111770-rheumatoid-nodule-hand-science-photo-library-high.jpg?mw=350&thn=0&sc_lang=en" alt="Rheumatoid" nodule="" (hand)="" loading="lazy" width="1000" height="665"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Rheumatoid Nodule (Hand)","Credits":"\u003cspan id=\u0022v85661520\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eDR P. MARAZZI/SCIENCE PHOTO LIBRARY \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"99870330-9b95-4eba-a157-2f2609a268a4","Title":"Rheumatoid%20Nodule%20%28Hand%29","ShareUrlTitle":"rheumatoid-nodule-hand","Description":"%3Cp%3EThis%20photo%20shows%20a%20rheumatoid%20nodule%20over%20the%20metacarpal%20joint%20of%20a%20patient%20with%20rheumatoid%20arthritis.%20%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/1/c0111770-rheumatoid-nodule-hand-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/1/c0111770-rheumatoid-nodule-hand-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34377299","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"665","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"Carousel-v41326894","LinkText":"Rheumatoid%20Nodule%20%28Hand%29","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Examples%20of%20Rheumatoid%20Nodule","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <figcaption class="inlinemedia__title mlr-0">Rheumatoid Nodule (Hand)</figcaption> <figcaption class="inlinemedia__description"><ul><span id="v88810753" class="anchor"></span><div class="para"> <p>This photo shows a rheumatoid nodule over the metacarpal joint of a patient with rheumatoid arthritis. </p></div></ul></figcaption> <figcaption class="inlinemedia__copyright"><span id="v85661520" class="anchor"></span><div class="para"> <p>DR P. MARAZZI/SCIENCE PHOTO LIBRARY </p></div></figcaption> </figure> </div> </div> <div class="tablebox__cell slidernav__next" role="button" tabindex="0" aria-label="Next"></div> </div> <div class="tablebox slidernav__dots"> <div class="tablebox__cell slidernav__fill"></div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="0" tabindex="0" role="button" aria-label="Indicator 0"></div> </div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="1" tabindex="0" role="button" aria-label="Indicator 1"></div> </div> <div class="tablebox__cell slidernav__dotwrapper"> <div class="slidernav__dot" data-slidenavid="2" tabindex="0" role="button" aria-label="Indicator 2"></div> </div> <div class="tablebox__cell slidernav__fill"></div> </div> </div> </div> </div> </section> </div> </section> <section id="v29657242" class="topic__section FHead"> <h2 id="Diagnosis_v29657243" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v29657243" class="anchor"></span> Diagnosis of Rheumatoid Arthritis </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657246" class="anchor"></span><div class="para"> <p>Clinical criteria</p></div></li><li class="topic__listitem"><span id="v29657248" class="anchor"></span><div class="para"> <p>Serum rheumatoid factor (RF), anticyclic citrullinated peptide (anti-CCP), and erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP)</p></div></li><li class="topic__listitem"><span id="v29657250" class="anchor"></span><div class="para"> <p>X-rays</p></div></li></ul></div><span id="v29657251" class="anchor"></span><div class="para"> <p>Rheumatoid arthritis should be suspected in patients with polyarticular, symmetric arthritis, particularly if the wrists and 2nd and 3rd metacarpophalangeal joints are involved. Classification criteria serve as a guide for establishing the diagnosis of rheumatoid arthritis and are helpful in defining standardized treatment populations for study purposes. Criteria include laboratory test results for RF, anti-CCP, and ESR or CRP (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"ca16c8da-1fd0-4466-b7d4-8c027424b314","Title":"Classification%20Criteria%20for%20Rheumatoid%20Arthritis","ShareUrlTitle":"classification-criteria-for-rheumatoid-arthritis","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v29657258","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EClassification%20Criteria%20for%20Rheumatoid%20Arthritis%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). However, diagnosis requires documented joint inflammation and should not be based on laboratory testing alone.</p></div><span id="v73980644" class="anchor"></span><div class="para"> <p>Other causes of symmetric polyarthritis, particularly hepatitis C, must be excluded. Obtaining baseline x-rays of affected joints should be considered to help document progression of disease (erosive changes, joint space narrowing) over time. In patients who have prominent lumbar symptoms, alternative diagnoses should be investigated. </p></div> <span id="v29657254"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v29657259"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"ca16c8da-1fd0-4466-b7d4-8c027424b314","Title":"Classification%20Criteria%20for%20Rheumatoid%20Arthritis","ShareUrlTitle":"classification-criteria-for-rheumatoid-arthritis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v29657258","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Classification%20Criteria%20for%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="ca16c8da-1fd0-4466-b7d4-8c027424b314"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'ca16c8da-1fd0-4466-b7d4-8c027424b314' }, async: true, success: function (data) { $('#ca16c8da-1fd0-4466-b7d4-8c027424b314').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v29657377" class="anchor"></span><div class="para"> <p>RFs, antibodies to human gamma-globulin, are present in about 70% of patients with rheumatoid arthritis. However, RF, often in low titers (levels can vary between laboratories), occurs in patients with other diseases, including </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v73980648" class="anchor"></span><div class="para"> <p>Other connective tissue diseases (eg, <a href="./{7E76F834-148A-4F02-BE62-DAF4ECBBDAAD}.html" data-toggle="tooltip" title="Systemic Lupus Erythematosus (SLE)" data-id="3fbd1b28-0e3d-4495-a9b7-2bea092aedfc" data-itemid="7e76f834-148a-4f02-be62-daf4ecbbdaad">systemic lupus erythematosus</a><span id="3fbd1b28-0e3d-4495-a9b7-2bea092aedfc" class="d-none xref"> <span class="tooltip-container"> <a href="./{7E76F834-148A-4F02-BE62-DAF4ECBBDAAD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Systemic Lupus Erythematosus (SLE) </span> Systemic lupus erythematosus is a chronic, multisystem, inflammatory disorder of autoimmune etiology, occurring predominantly in young women. Common manifestations may include arthralgias and... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/l/e/sle-9-5b-mckoy-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Systemic Lupus Erythematosus (SLE)" loading="lazy"> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v73980651" class="anchor"></span><div class="para"> <p>Granulomatous diseases</p></div></li><li class="topic__listitem"><span id="v73980653" class="anchor"></span><div class="para"> <p>Chronic infections (eg, <a href="./{47457341-B158-4F72-BD50-AC0EABE20B38}.html" data-toggle="tooltip" title="Overview of Acute Viral Hepatitis" data-id="4fef2299-bdbd-4012-84f3-d183ceb72df9" data-itemid="47457341-b158-4f72-bd50-ac0eabe20b38">viral hepatitis</a><span id="4fef2299-bdbd-4012-84f3-d183ceb72df9" class="d-none xref"> <span class="tooltip-container"> <a href="./{47457341-B158-4F72-BD50-AC0EABE20B38}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Acute Viral Hepatitis </span> Acute viral hepatitis is diffuse liver inflammation caused by specific hepatotropic viruses that have diverse modes of transmission and epidemiologies. A nonspecific viral prodrome is followed... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{007F21C7-05E6-4DBA-AF02-938BF2EBE0F9}.html" data-toggle="tooltip" title="Infective Endocarditis" data-id="9871fead-b79f-4c82-b691-cb8d42961e9c" data-itemid="007f21c7-05e6-4dba-af02-938bf2ebe0f9">bacterial endocarditis</a><span id="9871fead-b79f-4c82-b691-cb8d42961e9c" class="d-none xref"> <span class="tooltip-container"> <a href="./{007F21C7-05E6-4DBA-AF02-938BF2EBE0F9}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Infective Endocarditis </span> Infective endocarditis is infection of the endocardium, usually with bacteria (commonly, streptococci or staphylococci) or fungi. It may cause fever, heart murmurs, petechiae, anemia, embolic... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/8/8/e/88-endocarditis-slide-9a-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Infective Endocarditis" loading="lazy"> </span> </a> </span> </span>, <a href="./{1FEF1F26-C9F6-41EF-8C18-CB7450E146E0}.html" data-toggle="tooltip" title="Tuberculosis (TB)" data-id="b5878433-9954-430d-8545-8c11c03097d7" data-itemid="1fef1f26-c9f6-41ef-8c18-cb7450e146e0">tuberculosis</a><span id="b5878433-9954-430d-8545-8c11c03097d7" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FEF1F26-C9F6-41EF-8C18-CB7450E146E0}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Tuberculosis (TB) </span> Tuberculosis is a chronic, progressive mycobacterial infection, often with an asymptomatic latent period following initial infection. Tuberculosis most commonly affects the lungs. Symptoms include... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Tuberculosis (TB)" loading="lazy"> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v73980658" class="anchor"></span><div class="para"> <p>Cancers</p></div></li></ul></div><span id="v73980659" class="anchor"></span><div class="para"> <p>Low RF titers can also occur in 3% of the general population and 20% of older patients. Very high RF titers can occur in patients with hepatitis C infection and sometimes in patients with other chronic infections. An RF titer measured by latex agglutination of <span class='symbol'>></span> 1:80 or a positive anti-CCP test supports the diagnosis of rheumatoid arthritis in the appropriate clinical context, but other causes must be excluded.</p></div><span id="v29657378" class="anchor"></span><div class="para"> <p>Anti-CCP antibodies have high specificity (90%) and sensitivity (about 77 to 86%) for rheumatoid arthritis and, like RF, predict a worse prognosis. RF and anti-CCP values do not fluctuate with disease activity. Anti-CCP antibodies are notably absent in patients with hepatitis C who may have a positive RF titer and joint swelling related to the viral infection.</p></div> <div class="inlinemedia-component " data-ko-rebind="v29656909" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"X-Ray Features of Early Rheumatoid Arthritis","Credits":"\u003cspan id=\u0022v85663974\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eBy permission of the publisher. From Matteson E, Mason T: \u003cspan data-mmanualobjecttype=\u0022pubtitle\u0022\u003eAtlas of Rheumatology\u003c/span\u003e. Edited by G Hunder. Philadelphia, Current Medicine, 2005. \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"f03d6486-4203-480b-bac2-76cc22220a24","Title":"X-Ray Features of Early Rheumatoid Arthritis","ShareUrlTitle":"x-ray-features-of-early-rheumatoid-arthritis","Description":"\u003cul\u003e\u003cspan id=\u0022v88810757\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eFeatures of aggressive, early rheumatoid arthritis, as seen in this x-ray of a 61-year-old woman with rheumatoid arthritis for 1 year, include evidence of soft-tissue swelling of the metacarpophalangeal and proximal interphalangeal joints, periarticular osteoporosis, symmetric joint space narrowing of several metacarpophalangeal and proximal interphalangeal joints of both hands, and subtle erosions of the right 3rd and right and left 4th metacarpophalangeal joints.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/x/r/a/xray_early_ra_high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/x/r/a/xray_early_ra_high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v29656909","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"765","IframeSrc":null,"Target":null}'> </div><span id="v29657379" class="anchor"></span><div class="para"> <p>X-rays show only soft-tissue swelling during the first months of disease. Subsequently, periarticular osteoporosis, joint space (articular cartilage) narrowing, and marginal erosions may become visible. Erosions often develop within the first year but may occur any time. MRI seems to be more sensitive and detects earlier articular inflammation and erosions. In addition, abnormal subchondral bone signals (eg, bone marrow lesions, bone marrow edema) around the knee suggest progressive disease.</p></div><span id="v29657381" class="anchor"></span><div class="para"> <p>If rheumatoid arthritis is diagnosed, additional tests help detect complications and unexpected abnormalities. Complete blood count with differential should be obtained. A normochromic (or slightly hypochromic)-normocytic anemia occurs in 80%; hemoglobin is usually <span class='symbol'>></span> 10 g/dL (100 g/L). If hemoglobin is <span class='symbol'>≤</span> 10 g/dL (100 g/L), superimposed iron deficiency or other causes of anemia should be considered. Neutropenia occurs in 1 to 2% of cases, often with splenomegaly (Felty syndrome). Acute-phase reactants (eg, thrombocytosis, elevated ESR, elevated CRP) reflect disease activity. A mild polyclonal hypergammaglobulinemia often occurs. ESR is elevated in 90% of patients with active disease.</p></div><span id="v29657382" class="anchor"></span><div class="para"> <p>Validated measures of disease activity include the Rheumatoid Arthritis Disease Activity Score DAS-28 and Rheumatoid Arthritis Clinical Disease Activity Index.</p></div><span id="v29657391" class="anchor"></span><div class="para"> <p>Synovial fluid examination is necessary with any new-onset effusion to rule out other disorders and differentiate rheumatoid arthritis from other inflammatory arthritides (eg, septic and crystal-induced arthritis). In rheumatoid arthritis, during active joint inflammation, synovial fluid is turbid, yellow, and sterile, and usually has white blood cell counts 10,000 to 50,000/mcL (10.0 x10<sup>9</sup>/L to 50.0 x10<sup>9</sup>/L); polymorphonuclear leukocytes typically predominate, but <span class='symbol'>></span> 50% may be lymphocytes and other mononuclear cells. Crystals are absent.</p></div> <div class="inlinemedia-component " data-ko-rebind="v29657383" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/RheumatoidArthritisCDAI.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"3d74d960-9d9b-4135-8d15-9aceb916544d","Title":"Rheumatoid Arthritis Clinical Disease Activity Index CDAI","ShareUrlTitle":"rheumatoid-arthritis-clinical-disease-activity-index-cdai","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> <div class="inlinemedia-component " data-ko-rebind="v29657387" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/RheumatoidArthritisDAS28.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"322331e4-4684-4559-8ec4-37586ada9ef1","Title":"Rheumatoid Arthritis Disease Activity Score DAS-28","ShareUrlTitle":"rheumatoid-arthritis-disease-activity-score-das-28","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> <section id="v29657392" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v29657243_v29657393" class="topic__header--subsection"> <span id="v29657393" class="anchor"></span> Differential diagnosis </h3> <div class="topic__content"> <span id="v29657395" class="anchor"></span><div class="para"> <p>Many disorders can simulate rheumatoid arthritis:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657398" class="anchor"></span><div class="para"> <p> <a href="./{DFBD2E58-BC3E-43BB-839E-16D29E8A5EAD}.html" data-toggle="tooltip" title="Overview of Crystal-Induced Arthritides" data-id="ac18348e-062f-4a8c-a0ad-c8fa6e66d64f" data-itemid="dfbd2e58-bc3e-43bb-839e-16d29e8a5ead">Crystal-induced arthritis</a><span id="ac18348e-062f-4a8c-a0ad-c8fa6e66d64f" class="d-none xref"> <span class="tooltip-container"> <a href="./{DFBD2E58-BC3E-43BB-839E-16D29E8A5EAD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Crystal-Induced Arthritides </span> Arthritis can result from intra-articular deposition of crystals: Monosodium urate Calcium pyrophosphate dihydrate Basic calcium phosphate (apatite) Rarely, others such as calcium oxalate crystals <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v29657401" class="anchor"></span><div class="para"> <p> <a href="./{7E76F834-148A-4F02-BE62-DAF4ECBBDAAD}.html" data-toggle="tooltip" title="Systemic Lupus Erythematosus (SLE)" data-id="4002d538-9190-47f4-8faa-dcc3df22886b" data-itemid="7e76f834-148a-4f02-be62-daf4ecbbdaad">Systemic lupus erythematosus (SLE)</a><span id="4002d538-9190-47f4-8faa-dcc3df22886b" class="d-none xref"> <span class="tooltip-container"> <a href="./{7E76F834-148A-4F02-BE62-DAF4ECBBDAAD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Systemic Lupus Erythematosus (SLE) </span> Systemic lupus erythematosus is a chronic, multisystem, inflammatory disorder of autoimmune etiology, occurring predominantly in young women. Common manifestations may include arthralgias and... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/l/e/sle-9-5b-mckoy-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Systemic Lupus Erythematosus (SLE)" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v29657404" class="anchor"></span><div class="para"> <p> <a href="./{285BEC0C-210A-4E80-992E-46E28833CE13}.html" data-toggle="tooltip" title="Sarcoidosis" data-id="bc88f385-c4ea-40c4-93df-28dfa8dac6e8" data-itemid="285bec0c-210a-4e80-992e-46e28833ce13">Sarcoidosis</a><span id="bc88f385-c4ea-40c4-93df-28dfa8dac6e8" class="d-none xref"> <span class="tooltip-container"> <a href="./{285BEC0C-210A-4E80-992E-46E28833CE13}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sarcoidosis </span> Sarcoidosis is an inflammatory disorder resulting in noncaseating granulomas in one or more organs and tissues; etiology is unknown. The lungs and lymphatic system are most often affected, but... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/a/r/sarcoidosis-lung-histology-sah-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Sarcoidosis" loading="lazy"> </span> </a> </span> </span> (rarely causes a polyarticular arthritis)</p></div></li><li class="topic__listitem"><span id="v29657407" class="anchor"></span><div class="para"> <p> <a href="./{6B0C1A90-5EEC-445E-881E-0A2DF989A00E}.html" data-toggle="tooltip" title="Reactive Arthritis" data-id="ba4c63c5-afe3-4ffa-ba51-77d8ac7cce49" data-itemid="6b0c1a90-5eec-445e-881e-0a2df989a00e">Reactive arthritis</a><span id="ba4c63c5-afe3-4ffa-ba51-77d8ac7cce49" class="d-none xref"> <span class="tooltip-container"> <a href="./{6B0C1A90-5EEC-445E-881E-0A2DF989A00E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Reactive Arthritis </span> Reactive arthritis is an acute spondyloarthropathy that often seems precipitated by an infection, usually genitourinary or gastrointestinal. Common manifestations include asymmetric arthritis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/2/8/6/286_circinate_balanitis_slide_2_springer_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Reactive Arthritis" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v29657410" class="anchor"></span><div class="para"> <p> <a href="./{DBA85646-8ACA-4EE1-AD78-81A86E89A322}.html" data-toggle="tooltip" title="Psoriatic Arthritis" data-id="5f7f2edd-2ca4-4aef-b8a0-3577178823d3" data-itemid="dba85646-8aca-4ee1-ad78-81a86e89a322">Psoriatic arthritis</a><span id="5f7f2edd-2ca4-4aef-b8a0-3577178823d3" class="d-none xref"> <span class="tooltip-container"> <a href="./{DBA85646-8ACA-4EE1-AD78-81A86E89A322}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Psoriatic Arthritis </span> Psoriatic arthritis is a seronegative spondyloarthropathy and chronic inflammatory arthritis that occurs in people with psoriasis of the skin or nails. The arthritis is often asymmetric, and... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/s/o/psoriatic-arthritis-1-yaseen-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Psoriatic Arthritis" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v29657413" class="anchor"></span><div class="para"> <p> <a href="./{4901961E-3C3E-4D5F-832A-2C72CCD026DC}.html" data-toggle="tooltip" title="Ankylosing Spondylitis" data-id="83b6e86f-a302-4d03-92b7-f2816e37829b" data-itemid="4901961e-3c3e-4d5f-832a-2c72ccd026dc">Ankylosing spondylitis</a><span id="83b6e86f-a302-4d03-92b7-f2816e37829b" class="d-none xref"> <span class="tooltip-container"> <a href="./{4901961E-3C3E-4D5F-832A-2C72CCD026DC}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Ankylosing Spondylitis </span> Ankylosing spondylitis is the prototypical spondyloarthropathy and a systemic disorder characterized by inflammation of the axial skeleton, large peripheral joints, and digits; nocturnal back... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/1/m1100125-ankylosing-spondylitis-severe-kyphosis-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Ankylosing Spondylitis" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v29657416" class="anchor"></span><div class="para"> <p>Infectious causes such as <a href="./{ACB08406-520C-4D12-A579-B5D6FE6A8B6D}.html" data-toggle="tooltip" title="Hepatitis C, Chronic" data-id="903989e6-0bee-4cbd-b78d-b9e136e14de2" data-itemid="acb08406-520c-4d12-a579-b5d6fe6a8b6d">hepatitis C</a><span id="903989e6-0bee-4cbd-b78d-b9e136e14de2" class="d-none xref"> <span class="tooltip-container"> <a href="./{ACB08406-520C-4D12-A579-B5D6FE6A8B6D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hepatitis C, Chronic </span> Hepatitis C is a common cause of chronic hepatitis. It is often asymptomatic until manifestations of chronic liver disease occur. Diagnosis is confirmed by finding positive anti-HCV and positive... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{F4256ABC-05A9-408C-A254-F8345D14C64A}.html" data-toggle="tooltip" title="Erythema Infectiosum (Parvovirus B19 Infection)" data-id="f1e0d66d-0148-4e72-b93d-c657835dc9d8" data-itemid="f4256abc-05a9-408c-a254-f8345d14c64a">parvovirus B19</a><span id="f1e0d66d-0148-4e72-b93d-c657835dc9d8" class="d-none xref"> <span class="tooltip-container"> <a href="./{F4256ABC-05A9-408C-A254-F8345D14C64A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Erythema Infectiosum (Parvovirus B19 Infection) </span> Erythema infectiosum is caused by acute infection with human parvovirus B19. In children, it causes mild constitutional symptoms and a blotchy or maculopapular rash beginning on the cheeks and... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0220891_erythema_infectiosum_fifth_disease_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Erythema Infectiosum (Parvovirus B19 Infection)" loading="lazy"> </span> </a> </span> </span>, alpha virus, <a href="./{C7E8AB01-7E67-4842-AA5C-E766FC1969C4}.html" data-toggle="tooltip" title="Lyme Disease" data-id="865ec82c-f735-46a8-8b66-c82fdb0fba0d" data-itemid="c7e8ab01-7e67-4842-aa5c-e766fc1969c4">Lyme disease</a><span id="865ec82c-f735-46a8-8b66-c82fdb0fba0d" class="d-none xref"> <span class="tooltip-container"> <a href="./{C7E8AB01-7E67-4842-AA5C-E766FC1969C4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Lyme Disease </span> Lyme disease is a tick-transmitted infection caused by the spirochete <i>Borrelia</i> species. Early symptoms include an erythema migrans rash, which may be followed weeks to months later by... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/i/x/o/ixodes_scapularis_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Lyme Disease" loading="lazy"> </span> </a> </span> </span>, and <a href="./{6CC2F70C-3537-40D8-9CB5-DA4ABA39D4B5}.html" data-toggle="tooltip" title="Whipple Disease" data-id="2acb4255-79e3-4789-a21c-e584e3835d8c" data-itemid="6cc2f70c-3537-40d8-9cb5-da4aba39d4b5">Whipple disease</a><span id="2acb4255-79e3-4789-a21c-e584e3835d8c" class="d-none xref"> <span class="tooltip-container"> <a href="./{6CC2F70C-3537-40D8-9CB5-DA4ABA39D4B5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Whipple Disease </span> Whipple disease is a rare systemic illness caused by the bacterium <i>Tropheryma whipplei</i>. Main symptoms are arthritis, weight loss, abdominal pain, and diarrhea. Diagnosis is by small-bowel... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v29657418" class="anchor"></span><div class="para"> <p> <a href="./{9481812D-5690-4031-80FD-EC695FA4DDCA}.html" data-toggle="tooltip" title="Osteoarthritis (OA)" data-id="213c20cf-379e-4a5e-9d66-8b767f8a71f6" data-itemid="9481812d-5690-4031-80fd-ec695fa4ddca">Osteoarthritis </a><span id="213c20cf-379e-4a5e-9d66-8b767f8a71f6" class="d-none xref"> <span class="tooltip-container"> <a href="./{9481812D-5690-4031-80FD-EC695FA4DDCA}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Osteoarthritis (OA) </span> Osteoarthritis is a chronic arthropathy characterized by disruption and potential loss of joint cartilage along with other joint changes, including bone hypertrophy (osteophyte formation). Symptoms... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/h/e/b/heberdens_nodes_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Osteoarthritis (OA)" loading="lazy"> </span> </a> </span> </span></p></div></li></ul></div><span id="v29657421" class="anchor"></span><div class="para"> <p>Some patients with crystal-induced arthritis, especially <a href="./{5363D515-C316-4C17-AE75-845502EB6BE1}.html" data-toggle="tooltip" title="Calcium Pyrophosphate Arthritis" data-id="5fba59ad-cdfd-4228-81a8-1e0426e3c473" data-itemid="5363d515-c316-4c17-ae75-845502eb6be1">calcium pyrophosphate arthritis</a><span id="5fba59ad-cdfd-4228-81a8-1e0426e3c473" class="d-none xref"> <span class="tooltip-container"> <a href="./{5363D515-C316-4C17-AE75-845502EB6BE1}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Calcium Pyrophosphate Arthritis </span> Calcium pyrophosphate arthritis (CPP arthritis) involves intra-articular and/or extra-articular deposition of calcium pyrophosphate dihydrate (CPPD) crystals. Manifestations are protean and... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/1/c0174603_pseudogout_calcium_pyrophosphate_dihydrate_crystal_deposition_disease_science_photo_library_high_arrows.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Calcium Pyrophosphate Arthritis" loading="lazy"> </span> </a> </span> </span>, may meet criteria for rheumatoid arthritis; however, synovial fluid examination should clarify the diagnosis. The presence of crystals makes rheumatoid arthritis unlikely, although calcium pyrophosphate crystal disease and rheumatoid arthritis may coexist in the same patient. Joint involvement and subcutaneous nodules can result from SLE, gout, cholesterol, and <a href="./{F7EFCCB7-C123-4E3A-B851-3FA2DF819261}.html" data-toggle="tooltip" title="Amyloidosis" data-id="b30ae7a8-06f7-451d-ae9e-348be13e162c" data-itemid="f7efccb7-c123-4e3a-b851-3fa2df819261">amyloidosis</a><span id="b30ae7a8-06f7-451d-ae9e-348be13e162c" class="d-none xref"> <span class="tooltip-container"> <a href="./{F7EFCCB7-C123-4E3A-B851-3FA2DF819261}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Amyloidosis </span> Amyloidosis is any of a group of disparate conditions characterized by extracellular deposition of insoluble fibrils composed of misaggregated proteins. These proteins may accumulate locally... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/5/8/8/588-macroglossia-s182-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Amyloidosis" loading="lazy"> </span> </a> </span> </span> as well as rheumatoid arthritis; aspiration or biopsy of the nodules may occasionally be needed.</p></div><span id="v29657423" class="anchor"></span><div class="para"> <p> <a href="./{7E76F834-148A-4F02-BE62-DAF4ECBBDAAD}.html" data-toggle="tooltip" title="Systemic Lupus Erythematosus (SLE)" data-id="edf9a14d-50cb-4ee1-add9-86475726fa2b" data-itemid="7e76f834-148a-4f02-be62-daf4ecbbdaad">SLE</a><span id="edf9a14d-50cb-4ee1-add9-86475726fa2b" class="d-none xref"> <span class="tooltip-container"> <a href="./{7E76F834-148A-4F02-BE62-DAF4ECBBDAAD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Systemic Lupus Erythematosus (SLE) </span> Systemic lupus erythematosus is a chronic, multisystem, inflammatory disorder of autoimmune etiology, occurring predominantly in young women. Common manifestations may include arthralgias and... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/l/e/sle-9-5b-mckoy-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Systemic Lupus Erythematosus (SLE)" loading="lazy"> </span> </a> </span> </span> usually can be distinguished if there are skin lesions on light-exposed areas, hair loss, oral and nasal mucosal lesions, absence of joint erosions in even long-standing arthritis, joint fluid that often has white blood cell counts <span class='symbol'>&lt</span> 2000/mcL (2.0 x10<sup>9</sup>/L) (predominantly mononuclear cells), antibodies to double-stranded DNA, renal disease, and low serum complement levels. In contrast to rheumatoid arthritis, swan neck and ulnar deviation deformities in SLE are usually reducible.</p></div><span id="v29657425" class="anchor"></span><div class="para"> <p>Arthritis similar to rheumatoid arthritis can also occur in other rheumatic disorders (eg, <a href="./{D34C62B0-5E7B-4A77-96DC-81E9D95020C6}.html" data-toggle="tooltip" title="Polyarteritis Nodosa (PAN)" data-id="5407c582-0e63-4828-bc89-2fa1319d6e70" data-itemid="d34c62b0-5e7b-4a77-96dc-81e9d95020c6">polyarteritis</a><span id="5407c582-0e63-4828-bc89-2fa1319d6e70" class="d-none xref"> <span class="tooltip-container"> <a href="./{D34C62B0-5E7B-4A77-96DC-81E9D95020C6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Polyarteritis Nodosa (PAN) </span> Polyarteritis nodosa is a systemic necrotizing vasculitis that typically affects medium-sized muscular arteries and occasionally affects small muscular arteries, resulting in secondary tissue... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{D5C0C2A4-2A53-4289-AD63-596D87007007}.html" data-toggle="tooltip" title="Systemic Sclerosis" data-id="cae84d80-f031-4d81-b333-433355b59eec" data-itemid="d5c0c2a4-2a53-4289-ad63-596d87007007">systemic sclerosis</a><span id="cae84d80-f031-4d81-b333-433355b59eec" class="d-none xref"> <span class="tooltip-container"> <a href="./{D5C0C2A4-2A53-4289-AD63-596D87007007}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Systemic Sclerosis </span> Systemic sclerosis is a rare chronic disease of unknown cause characterized by diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs (especially the esophagus... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/y/s/systemic_sclerosis_hand_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Systemic Sclerosis" loading="lazy"> </span> </a> </span> </span>, <a href="./{0C270686-2BDA-447E-A018-75E6D942B197}.html" data-toggle="tooltip" title="Autoimmune Myositis" data-id="16dc2db8-80ee-4b32-bb8e-0c84a0cbc6e2" data-itemid="0c270686-2bda-447e-a018-75e6d942b197">dermatomyositis</a><span id="16dc2db8-80ee-4b32-bb8e-0c84a0cbc6e2" class="d-none xref"> <span class="tooltip-container"> <a href="./{0C270686-2BDA-447E-A018-75E6D942B197}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Autoimmune Myositis </span> Autoimmune myositis is characterized by inflammatory and degenerative changes in the muscles (polymyositis, necrotizing immune-mediated myopathy) or in the skin and muscles (dermatomyositis)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/5/0/7/507-heliotrope-rash-s103-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Autoimmune Myositis" loading="lazy"> </span> </a> </span> </span>, or <a href="./{0C270686-2BDA-447E-A018-75E6D942B197}.html" data-toggle="tooltip" title="Autoimmune Myositis" data-id="35ad74bb-a22b-4cf3-afc1-d83d94a55f3e" data-itemid="0c270686-2bda-447e-a018-75e6d942b197">polymyositis</a><span id="35ad74bb-a22b-4cf3-afc1-d83d94a55f3e" class="d-none xref"> <span class="tooltip-container"> <a href="./{0C270686-2BDA-447E-A018-75E6D942B197}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Autoimmune Myositis </span> Autoimmune myositis is characterized by inflammatory and degenerative changes in the muscles (polymyositis, necrotizing immune-mediated myopathy) or in the skin and muscles (dermatomyositis)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/5/0/7/507-heliotrope-rash-s103-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Autoimmune Myositis" loading="lazy"> </span> </a> </span> </span>), or there can be features of more than one disease, which suggests an <a href="./{90AD5DCF-DE01-47C7-93AD-3FB196198D99}.html" data-toggle="tooltip" title="Mixed Connective Tissue Disease (MCTD)" data-id="48bc9639-03da-48be-9de3-d4c953b528f6" data-itemid="90ad5dcf-de01-47c7-93ad-3fb196198d99">overlap syndrome</a><span id="48bc9639-03da-48be-9de3-d4c953b528f6" class="d-none xref"> <span class="tooltip-container"> <a href="./{90AD5DCF-DE01-47C7-93AD-3FB196198D99}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Mixed Connective Tissue Disease (MCTD) </span> Mixed connective tissue disease is an uncommon, specifically defined syndrome characterized by clinical features of systemic lupus erythematosus, systemic sclerosis, and polymyositis with very... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/2/r/42_raynaud_slide_4_springer_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Mixed Connective Tissue Disease (MCTD)" loading="lazy"> </span> </a> </span> </span>.</p></div><span id="v29657431" class="anchor"></span><div class="para"> <p> <a href="./{285BEC0C-210A-4E80-992E-46E28833CE13}.html" data-toggle="tooltip" title="Sarcoidosis" data-id="908c4ec6-c29c-4623-950d-69d65a2a8b94" data-itemid="285bec0c-210a-4e80-992e-46e28833ce13">Sarcoidosis</a><span id="908c4ec6-c29c-4623-950d-69d65a2a8b94" class="d-none xref"> <span class="tooltip-container"> <a href="./{285BEC0C-210A-4E80-992E-46E28833CE13}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sarcoidosis </span> Sarcoidosis is an inflammatory disorder resulting in noncaseating granulomas in one or more organs and tissues; etiology is unknown. The lungs and lymphatic system are most often affected, but... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/a/r/sarcoidosis-lung-histology-sah-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Sarcoidosis" loading="lazy"> </span> </a> </span> </span>, <a href="./{6CC2F70C-3537-40D8-9CB5-DA4ABA39D4B5}.html" data-toggle="tooltip" title="Whipple Disease" data-id="799f0d8d-4a27-421d-9950-69c822556814" data-itemid="6cc2f70c-3537-40d8-9cb5-da4aba39d4b5">Whipple disease</a><span id="799f0d8d-4a27-421d-9950-69c822556814" class="d-none xref"> <span class="tooltip-container"> <a href="./{6CC2F70C-3537-40D8-9CB5-DA4ABA39D4B5}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Whipple Disease </span> Whipple disease is a rare systemic illness caused by the bacterium <i>Tropheryma whipplei</i>. Main symptoms are arthritis, weight loss, abdominal pain, and diarrhea. Diagnosis is by small-bowel... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, multicentric reticulohistiocytosis, and other systemic diseases may involve joints; other clinical features and tissue biopsy sometimes help differentiate these conditions. Acute rheumatic fever has a migratory pattern of joint involvement and evidence of antecedent streptococcal infection (culture or changing antistreptolysin O titer); in contrast, rheumatoid arthritis tends to involve additional joints over time.</p></div><span id="v29657434" class="anchor"></span><div class="para"> <p> <a href="./{6B0C1A90-5EEC-445E-881E-0A2DF989A00E}.html" data-toggle="tooltip" title="Reactive Arthritis" data-id="589f8a0b-02a9-4d35-82ec-34028ca4e4b6" data-itemid="6b0c1a90-5eec-445e-881e-0a2df989a00e">Reactive arthritis</a><span id="589f8a0b-02a9-4d35-82ec-34028ca4e4b6" class="d-none xref"> <span class="tooltip-container"> <a href="./{6B0C1A90-5EEC-445E-881E-0A2DF989A00E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Reactive Arthritis </span> Reactive arthritis is an acute spondyloarthropathy that often seems precipitated by an infection, usually genitourinary or gastrointestinal. Common manifestations include asymmetric arthritis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/2/8/6/286_circinate_balanitis_slide_2_springer_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Reactive Arthritis" loading="lazy"> </span> </a> </span> </span> can be differentiated by antecedent gastrointestinal or genitourinary symptoms; asymmetric involvement and pain at the Achilles insertion of the heel, sacroiliac joints, and large joints of the leg; conjunctivitis; iritis; painless buccal ulcers; balanitis circinata; or keratoderma blennorrhagicum on the soles and elsewhere. </p></div><span id="v29657436" class="anchor"></span><div class="para"> <p> <a href="./{DBA85646-8ACA-4EE1-AD78-81A86E89A322}.html" data-toggle="tooltip" title="Psoriatic Arthritis" data-id="bee486e9-c32e-4dc8-a9f1-93fb9bede3e4" data-itemid="dba85646-8aca-4ee1-ad78-81a86e89a322">Psoriatic arthritis</a><span id="bee486e9-c32e-4dc8-a9f1-93fb9bede3e4" class="d-none xref"> <span class="tooltip-container"> <a href="./{DBA85646-8ACA-4EE1-AD78-81A86E89A322}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Psoriatic Arthritis </span> Psoriatic arthritis is a seronegative spondyloarthropathy and chronic inflammatory arthritis that occurs in people with psoriasis of the skin or nails. The arthritis is often asymmetric, and... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/s/o/psoriatic-arthritis-1-yaseen-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Psoriatic Arthritis" loading="lazy"> </span> </a> </span> </span> tends to be asymmetric and is not usually associated with RF, but clinical differentiation may be difficult in the absence of nail or skin lesions. Distal interphalangeal joint involvement and severely mutilating arthritis (arthritis mutilans) is strongly suggestive, as is the presence of a diffusely swollen (sausage) digit. Psoriatic arthritis may involve the sacroiliac joints and lower spine. Distinguishing between psoriatic arthritis and rheumatoid arthritis is important because response to some specific drugs differs. </p></div><span id="v29657439" class="anchor"></span><div class="para"> <p> <a href="./{4901961E-3C3E-4D5F-832A-2C72CCD026DC}.html" data-toggle="tooltip" title="Ankylosing Spondylitis" data-id="bb10305e-1b49-43c4-8ec5-91ed26495a00" data-itemid="4901961e-3c3e-4d5f-832a-2c72ccd026dc">Ankylosing spondylitis</a><span id="bb10305e-1b49-43c4-8ec5-91ed26495a00" class="d-none xref"> <span class="tooltip-container"> <a href="./{4901961E-3C3E-4D5F-832A-2C72CCD026DC}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Ankylosing Spondylitis </span> Ankylosing spondylitis is the prototypical spondyloarthropathy and a systemic disorder characterized by inflammation of the axial skeleton, large peripheral joints, and digits; nocturnal back... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/1/m1100125-ankylosing-spondylitis-severe-kyphosis-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Ankylosing Spondylitis" loading="lazy"> </span> </a> </span> </span> may be differentiated by spinal and axial joint involvement, absence of subcutaneous nodules, and a negative RF test. The HLA-B27 allele is present in 90% of White patients with ankylosing spondylitis. </p></div><span id="v29657441" class="anchor"></span><div class="para"> <p> <a href="./{9481812D-5690-4031-80FD-EC695FA4DDCA}.html" data-toggle="tooltip" title="Osteoarthritis (OA)" data-id="373c14ec-e81d-4228-9651-95f15647ee3c" data-itemid="9481812d-5690-4031-80fd-ec695fa4ddca">Osteoarthritis</a><span id="373c14ec-e81d-4228-9651-95f15647ee3c" class="d-none xref"> <span class="tooltip-container"> <a href="./{9481812D-5690-4031-80FD-EC695FA4DDCA}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Osteoarthritis (OA) </span> Osteoarthritis is a chronic arthropathy characterized by disruption and potential loss of joint cartilage along with other joint changes, including bone hypertrophy (osteophyte formation). Symptoms... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/h/e/b/heberdens_nodes_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Osteoarthritis (OA)" loading="lazy"> </span> </a> </span> </span> can be differentiated by the joints involved; the absence of rheumatoid nodules, systemic manifestations, or significant amounts of RF; and by synovial fluid white blood cell counts <span class='symbol'>&lt</span> 2000/mcL (2.0 x10<sup>9</sup>/L). Osteoarthritis of the hands most typically involves the DIP joints, bases of the thumbs, and proximal interphalangeal joints and may involve the metacarpophalangeal joints, but typically spares the wrist. Rheumatoid arthritis does not affect the DIP joints. Rheumatoid arthritis is characterized by clinically apparent, symmetric, small joint inflammation with frequent wrist involvement.</p></div> </div> </section> </div> </section> <section id="v29657443" class="topic__section FHead"> <h2 id="Prognosis_v29657444" class="topic__header--section" data-originaltitle="Prognosis"> <span id="v29657444" class="anchor"></span> Prognosis for Rheumatoid Arthritis </h2> <div class="topic__content"> <span id="v29657445" class="anchor"></span><div class="para"> <p>Rheumatoid arthritis decreases life expectancy by 3 to 7 years, with heart disease, infection, and gastrointestinal bleeding accounting for most excess mortality; drug treatment, cancer, as well as the underlying disease may be responsible. Disease activity should be controlled to lower cardiovascular disease risk in all patients with rheumatoid arthritis. (See also the European League Against Rheumatism's (EULAR) <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27697765">recommendations</a> for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders.)</p></div><span id="v29657447" class="anchor"></span><div class="para"> <p>At least 10% of patients are eventually severely disabled despite full treatment. White people and women have a poorer prognosis, as do patients with subcutaneous nodules, advanced age at disease onset, inflammation in <span class='symbol'>≥</span> 20 joints, early erosions, cigarette smoking, high erythrocyte sedimentation rate, and high levels of rheumatoid factor or anticyclic citrullinated peptide (anti-CCP).</p></div> </div> </section> <section id="v29657448" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v29657449" class="topic__header--section" data-originaltitle="Treatment"> <span id="v29657449" class="anchor"></span> Treatment of Rheumatoid Arthritis </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657453" class="anchor"></span><div class="para"> <p>Nonpharmacological measures: Smoking cessation, healthy, balanced nutrition, physical joint protective measures, quality sleep</p></div></li><li class="topic__listitem"><span id="v29657455" class="anchor"></span><div class="para"> <p>Pharmacological measures: Medications that modify disease progression and nonsteroidal anti-inflammatory drugs (NSAIDs) as needed for analgesia</p></div></li></ul></div><span id="v29657458" class="anchor"></span><div class="para"> <p>Treatment of rheumatoid arthritis involves a balance of rest and exercise, adequate nutrition, physical measures, drugs, and sometimes surgery. Early diagnosis and treatment in rheumatoid arthritis predict improved outcomes. A treat-to-target approach to achieve full disease remission or minimal disease activity has been recommended by the American College of Rheumatology (ACR) (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v73980673" data-toggle="tooltip" title="Treatment references" data-id="5727c36c-95a8-417f-8362-506527e28bac" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">1</a><span id="5727c36c-95a8-417f-8362-506527e28bac" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v73980673"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>) and European League Against Rheumatism (EULAR) (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v73980673" data-toggle="tooltip" title="Treatment references" data-id="c517b19e-99d2-4358-8b22-28ae1f96f03a" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">2</a><span id="c517b19e-99d2-4358-8b22-28ae1f96f03a" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v73980673"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>) recommendations for the management of rheumatoid arthritis. </p></div> <section id="v29657461" class="topic__section GHead"> <span></span> <h3 id="Treatment_v29657449_v29657462" class="topic__header--subsection"> <span id="v29657462" class="anchor"></span> Lifestyle measures </h3> <div class="topic__content"> <span id="v29657463" class="anchor"></span><div class="para"> <p>Complete bed rest is rarely indicated, even for a short time; however, a program including judicious rest should be encouraged. Quality sleep should be encouraged, because poor sleep increases pain.</p></div><span id="v29657464" class="anchor"></span><div class="para"> <p>An ordinary nutritious diet is appropriate. Rarely, patients have food-associated exacerbations; no specific foods have reproducibly been shown to exacerbate or lessen the symptoms of rheumatoid arthritis. Substituting omega-3 fatty acids (in fish oils) for dietary omega-6 fatty acids (in meats) partially relieves symptoms in some patients by transiently decreasing production of inflammatory prostaglandins and possibly by modifying the gut microbiome. Smoking cessation can increase life expectancy.</p></div><span id="v73980668" class="anchor"></span><div class="para"> <p>Food and diet misinformation targeting rheumatoid arthritis patients is common, and patients should be directed to reliable sources of information. </p></div> </div> </section> <section id="v29657465" class="topic__section GHead"> <span></span> <h3 id="Treatment_v29657449_v29657466" class="topic__header--subsection"> <span id="v29657466" class="anchor"></span> Physical measures </h3> <div class="topic__content"> <span id="v29657467" class="anchor"></span><div class="para"> <p>Joint splinting reduces local inflammation and may relieve severe symptoms of pain or compressive neuropathies. Cold may be applied to reduce joint pain and swelling. Orthopedic or athletic shoes with good heel and arch support are frequently helpful; metatarsal supports placed posteriorly (proximal) to painful metatarsophalangeal joints decrease the pain of weight bearing. Molded shoes may be needed for severe deformities. Occupational therapy and self-help devices enable many patients with debilitating rheumatoid arthritis to perform activities of daily living.</p></div><span id="v29657468" class="anchor"></span><div class="para"> <p>Exercise should proceed as tolerated. During acute inflammation, passive range-of-motion exercise helps prevent flexion contractures. Heat therapy can be applied to help alleviate stiffness. Range-of-motion exercises done in warm water are helpful because heat improves muscle function by reducing stiffness and muscle spasm. However, contractures can be prevented and muscle strength can be restored more successfully after inflammation begins to subside; active exercise (including walking and specific exercises for involved joints) to restore muscle mass and preserve range of joint motion are recommended. Flexion contractures may require intensive exercise, casting, or immobilization (eg, splinting) in progressively more stretched-open positions. Paraffin baths can warm digits and facilitate finger exercise.</p></div><span id="v29657469" class="anchor"></span><div class="para"> <p> <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129289" data-toggle="tooltip" title="Massage" data-id="767a182e-1f43-4227-abaa-b943c6f475ae" data-itemid="bb73a9b1-71bc-4025-b61c-e5c302904bb7">Massage</a><span id="767a182e-1f43-4227-abaa-b943c6f475ae" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129289"> <span class="tooltip-content"> <span class="tooltip-heading"> Massage </span> Treatment of pain and inflammation aims to facilitate movement and improve coordination of muscles and joints. Nonpharmacologic treatments include therapeutic exercise, heat, cold, electrical... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> by trained therapists, <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129285" data-toggle="tooltip" title="Cervical traction" data-id="d14d4bf0-44ca-4336-99bb-c0c95e5e6b01" data-itemid="bb73a9b1-71bc-4025-b61c-e5c302904bb7">traction</a><span id="d14d4bf0-44ca-4336-99bb-c0c95e5e6b01" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129285"> <span class="tooltip-content"> <span class="tooltip-heading"> Cervical traction </span> Treatment of pain and inflammation aims to facilitate movement and improve coordination of muscles and joints. Nonpharmacologic treatments include therapeutic exercise, heat, cold, electrical... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, and <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129258" data-toggle="tooltip" title="Heat" data-id="b86c1e18-5fb6-43f1-a89f-215f76b5c5fa" data-itemid="bb73a9b1-71bc-4025-b61c-e5c302904bb7">deep heat treatment</a><span id="b86c1e18-5fb6-43f1-a89f-215f76b5c5fa" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB73A9B1-71BC-4025-B61C-E5C302904BB7}.html#v1129258"> <span class="tooltip-content"> <span class="tooltip-heading"> Heat </span> Treatment of pain and inflammation aims to facilitate movement and improve coordination of muscles and joints. Nonpharmacologic treatments include therapeutic exercise, heat, cold, electrical... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> with diathermy or ultrasonography may be useful adjunctive therapies to anti-inflammatory drugs.</p></div> </div> </section> <section id="v29657470" class="topic__section GHead"> <span></span> <h3 id="Treatment_v29657449_v29657471" class="topic__header--subsection"> <span id="v29657471" class="anchor"></span> Surgery </h3> <div class="topic__content"> <span id="v29657472" class="anchor"></span><div class="para"> <p>Surgery may be considered if drug therapy is unsuccessful. Surgery must always be considered in terms of the total disease and patient expectations. For example, deformed hands and arms limit crutch use during rehabilitation; seriously affected knees and feet limit benefit from hip surgery. Reasonable objectives for each patient must be determined, and function must be considered; straightening ulnar-deviated fingers may not improve hand function. Surgery may be done while the disease is active.</p></div><span id="v29657473" class="anchor"></span><div class="para"> <p>Arthroplasty with prosthetic joint replacement is indicated if damage severely limits function; total hip and knee replacements are most consistently successful. Prosthetic hips and knees may limit vigorous activity (eg, competitive athletics). Excision of subluxed painful metatarsophalangeal joints may greatly aid walking. Thumb fusions may provide stability for pinch. Neck fusion may be needed for C1-2 subluxation with severe pain or potential for spinal cord compression. Arthroscopic or open synovectomy can relieve joint inflammation but only temporarily unless disease activity can be controlled. Withholding some immunosuppressive medications at the time of arthroplasty should be considered to limit the risk of infection. Even low-dose <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prednisone</span> (< 7.5 mg a day) may increase infectious risk.</p></div> </div> </section> <section id="v73980672" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v29657449_v73980673" class="topic__header--subsection"> <span itemprop="name" id="v73980673" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v73980676" class="anchor"></span><div class="para"> <p> 1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34101376/">Fraenkel L, Bathon JM, England BR, et al</a>: 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. <i>Arthritis Rheumatol</i> 73(7):1108-1123, 2021. doi:10.1002/art.41752</p></div></li><li class="topic__listitem"><span id="v73980679" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31969328/">Smolen JS, Landewé RBM, Bijlsma JWJ, et al</a>: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. <i>Ann Rheum Dis</i> 79(6):685-699, 2020. doi:10.1136/annrheumdis-2019-216655</p></div></li></ul></div> </div> </section> </div> </section> <section id="v29657474" class="topic__section FHead" itemprop="associatedAnatomy" itemscope="" itemtype="http://schema.org/AnatomicalStructure"> <h2 id="Other_v29657475" class="topic__header--section"> <span id="v29657475" class="anchor"></span> Drugs for Rheumatoid Arthritis </h2> <div class="topic__content"> <span id="v29657476" class="anchor"></span><div class="para"> <p>The goal is to reduce inflammation to prevent erosions, progressive deformity, and loss of joint function. A treat-to-target approach to achieve full disease remission or minimal disease activity has been suggested (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987" data-toggle="tooltip" title="Drugs for rheumatoid arthritis references" data-id="7d3097b9-68d6-4436-be00-71cf0141b819" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">1</a><span id="7d3097b9-68d6-4436-be00-71cf0141b819" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987"> <span class="tooltip-content"> <span class="tooltip-heading"> Drugs for rheumatoid arthritis references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Drugs for rheumatoid arthritis references" loading="lazy"> </span> </a> </span> </span>, <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987" data-toggle="tooltip" title="Drugs for rheumatoid arthritis references" data-id="bd515b1b-a1c7-4103-a400-dfd0893e47d4" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">2</a><span id="bd515b1b-a1c7-4103-a400-dfd0893e47d4" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987"> <span class="tooltip-content"> <span class="tooltip-heading"> Drugs for rheumatoid arthritis references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Drugs for rheumatoid arthritis references" loading="lazy"> </span> </a> </span> </span>). Disease-modifying antirheumatic drugs (DMARDs) are used early, often in combination. Biologic agents such as tumor necrosis factor (TNF)-alpha antagonists, an interleukin (IL)-1 receptor inhibitor, IL-6 blockers, B-cell depleters, T-cell costimulatory molecule modulators, and Janus kinase (JAK) inhibitors, seem to slow the progression of rheumatoid arthritis. Nonsteroidal anti-inflammatory drugs are of some help for the pain of rheumatoid arthritis, but they do not prevent erosions or disease progression, may slightly increase cardiovascular risk, and thus should be used as adjunctive therapy. Low-dose systemic corticosteroids (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prednisone</span> <span class='symbol'>&lt</span> 7.5 mg once/day) may be added to control severe polyarticular symptoms, usually with the objective of replacement with a DMARD. Intra-articular depot corticosteroids can control severe monarticular or even oligoarticular symptoms but with chronic use may have adverse metabolic effects, even in low doses. Studies indicate infectious and metabolic adverse effects from even low-dose chronic corticosteroid use, thus limitation of use is a treatment priority.</p></div><span id="v29657477" class="anchor"></span><div class="para"> <p>The optimal combinations of drugs are not yet clear. However, some data suggest that certain combinations of drugs from different classes (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> plus other DMARDs, a rapidly tapered corticosteroid plus a DMARD, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> plus a TNF-alpha antagonist, or a TNF-alpha antagonist plus a DMARD) are more effective than using DMARDs alone sequentially or in combination with other DMARDs. In general, biologic agents are not given in combination with each other due to increased frequency of infections. The following is an example of initial therapy:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657480" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Methotrexate</span> 10 to 15 mg orally once/week (with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>folic acid</span> 1 mg orally once/day) is given.</p></div></li><li class="topic__listitem"><span id="v29657482" class="anchor"></span><div class="para"> <p>If tolerated and not adequate, the dosage of weekly <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> is increased at 3- to 5-week intervals to a maximum of 25 mg orally or by injection (oral bioavailability decreases above 15 mg in a single dose).</p></div></li><li class="topic__listitem"><span id="v29657484" class="anchor"></span><div class="para"> <p>If response is not adequate, a biologic agent is usually added. Alternatively, triple therapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sulfasalazine</span> is a cost-effective option, but long-term tolerability is challenging. </p></div></li></ul></div><span id="v29657485" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Leflunomide</span> may be used instead of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> or added to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> with close monitoring of serum transaminase levels and complete blood count.</p></div><span id="v73980683" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Methotrexate</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>leflunomide</span> (and some other medications) must be avoided if pregnancy is anticipated.</p></div> <section id="v29657486" class="topic__section GHead"> <span></span> <h3 id="Other_v29657475_v29657487" class="topic__header--subsection"> <span id="v29657487" class="anchor"></span> Nonsteroidal anti-inflammatory drugs (NSAIDs) </h3> <div class="topic__content"> <span id="v29657489" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aspirin</span> is no longer used for rheumatoid arthritis because effective doses are often toxic. Only one NSAID should be given at a time (see table <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657518" data-toggle="tooltip" title="Nonsteroidal Anti-inflammatory Drug (NSAID) Treatment of Rheumatoid Arthritis" data-id="760549c8-ad97-4d6b-b9dd-9f2e0e4fdbcd" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">NSAID Treatment of Rheumatoid Arthritis</a><span id="760549c8-ad97-4d6b-b9dd-9f2e0e4fdbcd" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657518"> <span class="tooltip-content"> <span class="tooltip-heading"> Nonsteroidal Anti-inflammatory Drug (NSAID) Treatment of Rheumatoid Arthritis </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="Nonsteroidal Anti-inflammatory Drug (NSAID) Treatment of Rheumatoid Arthritis" loading="lazy"> </span> </a> </span> </span>), although patients may also take <span class="genericDrug" data-showrollover="false">aspirin</span> at <span class='symbol'>≤</span> 325 mg/day for its antiplatelet cardioprotective effect. Because the maximal response for NSAIDs can take up to 2 weeks, doses should be increased no more frequently than this. Doses of drugs with flexible dosing can be increased until response is maximal or maximum dosage is reached. All NSAIDs treat the symptoms of rheumatoid arthritis and decrease inflammation but do not alter the course of the disease; thus, they are only used adjunctively.</p></div><span id="v29657491" class="anchor"></span><div class="para"> <p>NSAIDs inhibit cyclooxygenase (COX) enzymes and thus decrease production of prostaglandins. Some prostaglandins under COX-1 control have important effects in many parts of the body (ie, they protect gastric mucosa and inhibit platelet adhesiveness). Other prostaglandins are induced by inflammation and are produced by COX-2. Selective COX-2 inhibitors, also called coxibs (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>celecoxib</span>), seem to have efficacy similar to nonselective NSAIDs and are slightly less likely to cause gastrointestinal toxicity; however, they are not less likely to cause renal toxicity. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Celecoxib</span> 200 mg orally once/day has a comparable cardiovascular safety profile to nonselective NSAIDs. It remains unclear whether full-dose <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>celecoxib</span> (200 mg orally 2 times a day ) has cardiovascular risks comparable to the nonselective NSAIDs.</p></div><span id="v29657492" class="anchor"></span><div class="para"> <p>NSAIDs should generally be avoided in patients with previous peptic ulcer disease or dyspepsia; gastric acid suppressive therapy should be provided in these patients if an NSAID is used (eg, short term). Other possible adverse effects of all NSAIDs include headache, confusion and other central nervous system symptoms, increased blood pressure, worsening of hypertension, edema, and decreased platelet function; however, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>celecoxib</span> has no significant antiplatelet effect. NSAIDs may increase cardiovascular risk (see <a href="./{8547D22A-3ACE-40D1-B051-7181888831FD}.html#v1032984" data-toggle="tooltip" title="Nonopioid Analgesics" data-id="18adbb6e-7193-4a60-bfd6-e704562ee2c7" data-itemid="8547d22a-3ace-40d1-b051-7181888831fd">Treatment of Pain/Nonopioid Analgesics</a><span id="18adbb6e-7193-4a60-bfd6-e704562ee2c7" class="d-none xref"> <span class="tooltip-container"> <a href="./{8547D22A-3ACE-40D1-B051-7181888831FD}.html#v1032984"> <span class="tooltip-content"> <span class="tooltip-heading"> Nonopioid Analgesics </span> <span class="tooltip-readmore"> </span> </span> </a> </span> </span>). Creatinine levels can rise reversibly because of inhibited renal prostaglandins and reduced renal blood flow; rarely, interstitial nephritis can occur. Patients with urticaria, rhinitis, or asthma caused by <span class="genericDrug" data-showrollover="false">aspirin</span> can have the same problems with these other NSAIDs, but <span class="genericDrug" data-showrollover="false">celecoxib</span> may not cause these problems. </p></div><span id="v29657494" class="anchor"></span><div class="para"> <p>NSAIDs should be used at the lowest possible dose needed to mitigate their adverse effects.</p></div> <span id="v29657495"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v29657518"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"2827eb2d-16ab-4791-930e-ba248e2049c8","Title":"Nonsteroidal%20Anti-inflammatory%20Drug%20%28NSAID%29%20Treatment%20of%20Rheumatoid%20Arthritis","ShareUrlTitle":"nonsteroidal-anti-inflammatory-drug-nsaid-treatment-of-rheumatoid-arthritis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v29657517","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Nonsteroidal%20Anti-inflammatory%20Drug%20%28NSAID%29%20Treatment%20of%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="2827eb2d-16ab-4791-930e-ba248e2049c8"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '2827eb2d-16ab-4791-930e-ba248e2049c8' }, async: true, success: function (data) { $('#2827eb2d-16ab-4791-930e-ba248e2049c8').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v29657665" class="topic__section GHead"> <span></span> <h3 id="Other_v29657475_v29657666" class="topic__header--subsection"> <span id="v29657666" class="anchor"></span> Traditional disease-modifying antirheumatic drugs (DMARDs) </h3> <div class="topic__content"> <span id="v29657668" class="anchor"></span><div class="para"> <p>(See table <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657695" data-toggle="tooltip" title="Other Drugs Used to Treat Rheumatoid Arthritis" data-id="91648d07-86ca-41d6-a2bd-47c444cca84b" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">Other Drugs Used to Treat Rheumatoid Arthritis</a><span id="91648d07-86ca-41d6-a2bd-47c444cca84b" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657695"> <span class="tooltip-content"> <span class="tooltip-heading"> Other Drugs Used to Treat Rheumatoid Arthritis </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="./Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="Other Drugs Used to Treat Rheumatoid Arthritis" loading="lazy"> </span> </a> </span> </span> for specific dosage information and adverse effects of other drugs used to treat rheumatoid arthritis.)</p></div><span id="v29657670" class="anchor"></span><div class="para"> <p>DMARDs seem to slow the progression of rheumatoid arthritis and are indicated for nearly all patients with rheumatoid arthritis. They differ from each other chemically and pharmacologically. Many take weeks or months to have an effect. About two thirds of patients improve overall, and complete remissions are becoming more common. Many DMARDs result in evidence of decreased damage on imaging studies, presumably reflecting decreased disease activity. Patients should be fully apprised of the risks of DMARDs and monitored closely for evidence of toxicity.</p></div> <span id="v29657671"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v29657695"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"b2c02bc3-78f8-4684-806c-c1fd170b790b","Title":"Other%20Drugs%20Used%20to%20Treat%20Rheumatoid%20Arthritis","ShareUrlTitle":"other-drugs-used-to-treat-rheumatoid-arthritis","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v29657694","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Other%20Drugs%20Used%20to%20Treat%20Rheumatoid%20Arthritis","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="b2c02bc3-78f8-4684-806c-c1fd170b790b"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'b2c02bc3-78f8-4684-806c-c1fd170b790b' }, async: true, success: function (data) { $('#b2c02bc3-78f8-4684-806c-c1fd170b790b').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v29657956" class="anchor"></span><div class="para"> <p>When choosing DMARDs, the following principles should be considered:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657959" class="anchor"></span><div class="para"> <p>Combinations of DMARDs may be more effective than single drugs. For example, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sulfasalazine</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> together are more effective than <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> alone or the other two together.</p></div></li><li class="topic__listitem"><span id="v29657961" class="anchor"></span><div class="para"> <p>Combining a DMARD with another drug, such as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> plus a tumor necrosis factor (TNF)-alpha antagonist or a rapidly tapered corticosteroid, may be more effective than using DMARDs alone.</p></div></li></ul></div><span id="v29657962" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Methotrexate</span></b> is a folate antagonist with immunosuppressive effects at high dose. It is anti-inflammatory at doses used in rheumatoid arthritis. It is very effective and has a relatively rapid onset (clinical benefit often within 3 to 4 weeks). <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Methotrexate</span> should be used with caution, if at all, in patients with hepatic dysfunction or renal failure. Alcohol should be avoided. Supplemental folate, 1 mg orally once/day, reduces the likelihood of adverse effects. Complete blood count (CBC), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>albumin</span> and creatinine level should be determined about every 8 to 12 weeks. When used early in the course of rheumatoid arthritis, efficacy may equal the biologic agents. Rarely, a liver biopsy is needed if liver test findings are persistently twice the upper limit of normal or more and the patient needs to continue to use <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span>. Severe relapses of arthritis can occur after withdrawal of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span>. Paradoxically, rheumatoid nodules may enlarge with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> therapy. In rheumatoid arthritis patients with stable parenchymal lung disease, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> can be continued with close monitoring of their respiratory status, if the <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> is controlling joint inflammation.</p></div><span id="v29657963" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span></b> can also control symptoms of mild rheumatoid arthritis. Funduscopic examination should be done and visual fields should be assessed before and every 12 months during treatment. The drug should be stopped if no joint improvement occurs after 9 months.</p></div><span id="v29657964" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sulfasalazine</span></b> can alleviate symptoms and slow development of joint damage. It is usually given as enteric-coated tablets. Benefit should occur within 3 months. Enteric coating or dose reduction may increase tolerability. Because neutropenia may occur early, CBCs should be obtained after 1 to 2 weeks and then about every 12 weeks during therapy. AST and ALT should be obtained at about 6-month intervals and whenever the dose is increased. In male patients, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sulfasalazine</span> may cause reversible oligospermia. </p></div><span id="v29657965" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Leflunomide</span></b> interferes with an enzyme involved with pyrimidine metabolism. It is about as effective as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> but is less likely to suppress bone marrow, cause abnormal liver function, or cause pneumonitis. Alopecia and diarrhea are fairly common at the onset of therapy but may resolve with continuation of therapy.</p></div> </div> </section> <section id="v29657967" class="topic__section GHead"> <span></span> <h3 id="Other_v29657475_v29657968" class="topic__header--subsection"> <span id="v29657968" class="anchor"></span> Corticosteroids </h3> <div class="topic__content"> <span id="v29657969" class="anchor"></span><div class="para"> <p>Systemic corticosteroids decrease inflammation and other symptoms more rapidly and to a greater degree than other drugs. They may not prevent joint destruction, and their clinical benefit often diminishes with time. Furthermore, rebound often follows the withdrawal of corticosteroids in active disease. Because of their long-term adverse effects, some doctors recommend that corticosteroids are given only for short periods of time to maintain function until a DMARD has taken effect. </p></div><span id="v29657970" class="anchor"></span><div class="para"> <p>Corticosteroids may be used for severe joint or systemic manifestations of rheumatoid arthritis (eg, vasculitis, pleurisy, pericarditis). Relative contraindications include peptic ulcer disease, hypertension, untreated infections, diabetes mellitus, and glaucoma. The risk of latent tuberculosis should be considered before corticosteroid therapy is begun.</p></div><span id="v29657971" class="anchor"></span><div class="para"> <p><b>Intra-articular injections</b> of depot corticosteroids may temporarily help control pain and swelling in particularly painful joints. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Triamcinolone</span> hexacetonide may suppress inflammation for the longest time. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Triamcinolone</span> acetonide and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methylprednisolone</span> acetate are also effective. No single joint should be injected with a corticosteroid more than 3 to 4 times a year, as too-frequent injections may accelerate joint destruction (although there are no specific data from humans to support this effect). Because injectable corticosteroid esters are crystalline, local inflammation transiently increases within a few hours in <span class='symbol'>&lt</span> 2% of patients receiving injections. Although infection occurs in only <span class='symbol'>&lt</span> 1:40,000 patients, it must be considered if pain occurs <span class='symbol'>></span> 24 hours after injection.</p></div> </div> </section> <section id="v29657972" class="topic__section GHead"> <span></span> <h3 id="Other_v29657475_v29657973" class="topic__header--subsection"> <span id="v29657973" class="anchor"></span> Immunomodulatory, cytotoxic, and immunosuppressive drugs </h3> <div class="topic__content"> <span id="v29657974" class="anchor"></span><div class="para"> <p>Treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>azathioprine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cyclosporine</span> (an immunomodulatory drug) may provide efficacy similar to DMARDs. However, these drugs are more toxic and less well studied. Thus, they are used only for patients in whom treatment with more traditional DMARDs has failed. They are used infrequently unless there are extra-articular complications.</p></div> </div> </section> <section id="v29657975" class="topic__section GHead"> <span></span> <h3 id="Other_v29657475_v29657976" class="topic__header--subsection"> <span id="v29657976" class="anchor"></span> Biologic agents </h3> <div class="topic__content"> <span id="v29657981" class="anchor"></span><div class="para"> <p><b>Tumor necrosis factor (TNF)-alpha antagonists</b> (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>adalimumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>etanercept</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>golimumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>certolizumab pegol</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>infliximab</span>, and their biosimilars) reduce the progression of erosions and reduce the number of new erosions. Although not all patients respond, many have a prompt, dramatic feeling of well being, sometimes with the first injection. Inflammation is often dramatically reduced. These drugs are often added to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> therapy to increase the effect and possibly prevent the development of drug-neutralizing antibodies.</p></div><span id="v41326976" class="anchor"></span><div class="para"> <p>Recent information suggests safety during pregnancy with TNF inhibitors and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>anakinra</span> (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987" data-toggle="tooltip" title="Drugs for rheumatoid arthritis references" data-id="71822bfb-52f5-4f48-9f20-160d573f5064" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">3</a><span id="71822bfb-52f5-4f48-9f20-160d573f5064" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987"> <span class="tooltip-content"> <span class="tooltip-heading"> Drugs for rheumatoid arthritis references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Drugs for rheumatoid arthritis references" loading="lazy"> </span> </a> </span> </span>). TNF-alpha antagonists should probably be stopped before major surgery to decrease the risk of perioperative infection (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987" data-toggle="tooltip" title="Drugs for rheumatoid arthritis references" data-id="53381013-e0fd-45cb-b3cb-0a14328f928d" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">4</a><span id="53381013-e0fd-45cb-b3cb-0a14328f928d" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987"> <span class="tooltip-content"> <span class="tooltip-heading"> Drugs for rheumatoid arthritis references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Drugs for rheumatoid arthritis references" loading="lazy"> </span> </a> </span> </span>). <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Etanercept</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>infliximab</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>adalimumab</span> can be used with or without <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span>. TNF inhibitors may predispose to heart failure and thus are relatively contraindicated in stage 3 and stage 4 heart failure. There is a minimal risk of lymphoma in rheumatoid arthritis patients who are being treated with TNF inhibitors. 2015 ACR guidelines conditionally recommended using DMARDs, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rituximab</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abatacept</span> instead of TNF inhibitors in patients with history of lymphoma (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987" data-toggle="tooltip" title="Drugs for rheumatoid arthritis references" data-id="d66015a1-c406-48aa-8689-46bf614f329c" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">5</a><span id="d66015a1-c406-48aa-8689-46bf614f329c" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987"> <span class="tooltip-content"> <span class="tooltip-heading"> Drugs for rheumatoid arthritis references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Drugs for rheumatoid arthritis references" loading="lazy"> </span> </a> </span> </span>). Evidence regarding solid tumors in TNF inhibitors is mixed. Other possible adverse events of TNF inhibitors include injection site reaction, acute and delayed infusion reaction, demyelinating disease, granulomatous diseases such as sarcoidosis, cytopenias (especially neutropenia), cutaneous vasculitis, and rarely antineutrophilic cytoplasmic associated vasculitis. </p></div><span id="v41326978" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sarilumab</span></b> is an interleukin-6 (IL-6) inhibitor. It is available for adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to or are intolerant of one or more DMARDs.</p></div><span id="v29657982" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tocilizumab</span></b> is an IL-6 inhibitor and has clinical efficacy in patients who have responded incompletely to other biologic agents.</p></div><span id="v73980696" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Abatacept</span>,</b> a soluble fusion cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) Ig, is indicated for patients with rheumatoid arthritis with an inadequate response to other DMARDs, and conditionally recommended over other biologic DMARDs in patients with rheumatoid arthritis and non-tuberculous mycobacterial lung disease.</p></div><span id="v73980697" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Anakinra</span></b> is a recombinant interleukin-1 (IL-1) receptor. IL-1 is heavily involved in the pathogenesis of rheumatoid arthritis. Infection and leukopenia can be problems. It is used less often because it must be given every day.</p></div><span id="v73980698" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rituximab</span> </b>is an anti-CD 20 antibody that depletes B cells. It can be used in patients refractory to other treatments. Response is often delayed but may last 6 months. The course can be repeated after 6 months. Mild adverse effects are common, and analgesia, corticosteroids, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>diphenhydramine</span>, or a combination may need to be given concomitantly. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rituximab</span> therapy has been associated with progressive multifocal leukoencephalopathy (as have other immunosuppressive drugs), mucocutaneous reactions, delayed leukopenia, and hepatitis B reactivation with hepatic necrosis. Patients on <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rituximab</span> may have a blunted immune response to the <a href="./{15803A40-86F8-457C-9891-8DE8532EDB52}.html" data-toggle="tooltip" title="COVID-19 Vaccine" data-id="ecb7539e-9e15-490e-bcd2-a38d89e79104" data-itemid="15803a40-86f8-457c-9891-8de8532edb52"> COVID-19 vaccine</a><span id="ecb7539e-9e15-490e-bcd2-a38d89e79104" class="d-none xref"> <span class="tooltip-container"> <a href="./{15803A40-86F8-457C-9891-8DE8532EDB52}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> COVID-19 Vaccine </span> COVID-19 vaccines provide protection against COVID-19, the disease caused by infection with the SARS-CoV-2 virus. Vaccination is the most effective strategy to prevent severe illness and death... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and have poorer outcomes if infected with SARS-CoV-2. Therefore, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rituximab</span> is now generally reserved for patients who did not respond to other biologic DMARDs (including a combined TNF-alpha inhibitor and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span>) and to those with lymphoproliferative disorders. </p></div><span id="v73980700" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rituximab</span> therapy might be gradually discontinued if the patient has had low disease activity or been in remission for at least 6 months.</p></div><span id="v29657984" class="anchor"></span><div class="para"> <p>Although there are some differences among agents, the most serious concern with the biologics and targeted DMARDs is infection, particularly with reactivated tuberculosis. Patients should be <a href="./{1FEF1F26-C9F6-41EF-8C18-CB7450E146E0}.html#v1011186" data-toggle="tooltip" title="Screening for TB" data-id="eb13ed3e-5bbf-4d85-b36e-f13fb28b7c89" data-itemid="1fef1f26-c9f6-41ef-8c18-cb7450e146e0">screened for tuberculosis</a><span id="eb13ed3e-5bbf-4d85-b36e-f13fb28b7c89" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FEF1F26-C9F6-41EF-8C18-CB7450E146E0}.html#v1011186"> <span class="tooltip-content"> <span class="tooltip-heading"> Screening for TB </span> Tuberculosis is a chronic, progressive mycobacterial infection, often with an asymptomatic latent period following initial infection. Tuberculosis most commonly affects the lungs. Symptoms include... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/2/7/m2700245-tuberculosis-chest-x-ray-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Screening for TB" loading="lazy"> </span> </a> </span> </span> with purified protein derivative (PPD) or an interferon-gamma release assay. Other serious infections can occur, including sepsis, invasive fungal infections, and infections due to other opportunistic organisms. Patients should be <a href="./{A96CADD2-311D-4955-865F-A7F862D72170}.html" data-toggle="tooltip" title="Overview of Immunization" data-id="68bd34be-304d-4a30-b0a6-7a5495c33a4d" data-itemid="a96cadd2-311d-4955-865f-a7f862d72170">up to date on vaccinations</a><span id="68bd34be-304d-4a30-b0a6-7a5495c33a4d" class="d-none xref"> <span class="tooltip-container"> <a href="./{A96CADD2-311D-4955-865F-A7F862D72170}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Immunization </span> Immunity can be achieved Actively by using antigens (eg, vaccines, toxoids) Passively by using antibodies (eg, immune globulins, antitoxins) A toxoid is a bacterial toxin that has been modified... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> prior to treatment with a biologic agent. </p></div> </div> </section> <section id="v74250353" class="topic__section GHead"> <span></span> <h3 id="Other_v29657475_v74250354" class="topic__header--subsection"> <span id="v74250354" class="anchor"></span> Janus kinase (JAK) inhibitors </h3> <div class="topic__content"> <span id="v74250355" class="anchor"></span><div class="para"> <p>Janus kinase (JAK) inhibitors are small molecule agents that interfere with the communication between cells that coordinate inflammation by inhibiting the enzyme JAK. JAK inhibitors include <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tofacitinib</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>baricitinib</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>upadacitinib</span>. (See also table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"b2c02bc3-78f8-4684-806c-c1fd170b790b","Title":"Other%20Drugs%20Used%20to%20Treat%20Rheumatoid%20Arthritis","ShareUrlTitle":"other-drugs-used-to-treat-rheumatoid-arthritis","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v29657694","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EOther%20Drugs%20Used%20to%20Treat%20Rheumatoid%20Arthritis%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>.) JAK inhibitors carry an increased incidence of herpes zoster, thus <a href="./{2E4AC52B-F31A-4AEC-8DB9-835F4DD68774}.html" data-toggle="tooltip" title="Herpes Zoster Vaccine" data-id="ba1afeba-b3d4-428f-9b50-ba2f12a37559" data-itemid="2e4ac52b-f31a-4aec-8db9-835f4dd68774">vaccination against zoster</a><span id="ba1afeba-b3d4-428f-9b50-ba2f12a37559" class="d-none xref"> <span class="tooltip-container"> <a href="./{2E4AC52B-F31A-4AEC-8DB9-835F4DD68774}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Herpes Zoster Vaccine </span> Chickenpox (varicella) and shingles ( herpes zoster) are caused by the varicella-zoster virus; chickenpox is the acute invasive phase of the virus, and shingles represents reactivation of the... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> is strongly suggested prior to use of these medications.</p></div><span id="v41326979" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Baricitinib</span></b> is an oral Janus kinase (JAK) inhibitor. It is indicated for adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonists.</p></div><span id="v29657983" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tofacitinib</span></b> is a JAK inhibitor that is given orally with or without concomitant <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> to patients who do not respond to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span> alone or other biologic agents. </p></div><span id="v48477211" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Upadacitinib</span></b> is a JAK inhibitor that is given orally to adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span>. Other JAK inhibitors that may soon become available in the US include filgotinib and peficitinib. </p></div><span id="v73980694" class="anchor"></span><div class="para"> <p>A prospective, randomized, open-label study compared the JAK inhibitor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tofacitinib</span> (5 and 10 mg doses) with TNF-alpha antagonists. After a median follow-up of 4 years, the results showed a higher risk of major adverse cardiovascular events (MACEs) and cancer with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tofacitinib</span> than with TNF-alpha antagonists, especially in patients over age 50 years and with at least 1 risk factor for cardiovascular disease (<a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987" data-toggle="tooltip" title="Drugs for rheumatoid arthritis references" data-id="4ce54734-f822-4463-bea2-40961c40082c" data-itemid="85563e6b-c6c5-4019-8939-abf04ba7bed4">6</a><span id="4ce54734-f822-4463-bea2-40961c40082c" class="d-none xref"> <span class="tooltip-container"> <a href="./{85563E6B-C6C5-4019-8939-ABF04BA7BED4}.html#v29657987"> <span class="tooltip-content"> <span class="tooltip-heading"> Drugs for rheumatoid arthritis references </span> Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily involves the joints. Rheumatoid arthritis causes damage mediated by cytokines, chemokines, and metalloproteases.... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/0/c0095323_swans_neck_deformity_hands_with_rheumatoid_arthritis_science_photo_library_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Drugs for rheumatoid arthritis references" loading="lazy"> </span> </a> </span> </span>). </p></div> </div> </section> <section id="v29657986" class="topic__section GHead"> <span></span> <h3 id="Other_v29657475_v29657987" class="topic__header--subsection"> <span id="v29657987" class="anchor"></span> Drugs for rheumatoid arthritis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v73980705" class="anchor"></span><div class="para"> <p> 1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34101376/">Fraenkel L, Bathon JM, England BR, et al</a>: 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. <i>Arthritis Rheumatol</i> 73(7):1108-1123, 2021. doi:10.1002/art.41752</p></div></li><li class="topic__listitem"><span id="v73980708" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31969328/">Smolen JS, Landewé RBM, Bijlsma JWJ, et al</a>: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. <i>Ann Rheum Dis</i> 79(6):685-699, 2020. doi:10.1136/annrheumdis-2019-216655</p></div></li><li class="topic__listitem"><span id="v73980711" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32090466/">Sammaritano LR, Bermas BL, Chakravarty EE, et al</a>: 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. <i>Arthritis Care Res (Hoboken) </i>72(4):461-488, 2020. doi:10.1002/acr.24130</p></div></li><li class="topic__listitem"><span id="v73980714" class="anchor"></span><div class="para"> <p> 4. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35718887/">Goodman SM, Springer BD, Chen AF, et al</a>: 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. <i>Arthritis Care Res (Hoboken)</i> 74(9):1399-1408, 2022. doi:10.1002/acr.24893</p></div></li><li class="topic__listitem"><span id="v73980717" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/26545940/">Singh JA, Saag KG, Bridges SL Jr, et al</a>: 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. <i>Arthritis Rheumatol</i> 68(1):1-26, 2016. doi:10.1002/art.39480</p></div></li><li class="topic__listitem"><span id="v73980720" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35081280/">Ytterberg SR, Bhatt DL, Mikuls TR, et al</a>: Cardiovascular and cancer risk with <span class="genericDrug" data-showrollover="false">tofacitinib</span> in rheumatoid arthritis. <i>N Engl J Med</i> 386(4):316-326, 2022. doi:10.1056/NEJMoa2109927</p></div></li></ul></div> </div> </section> </div> </section> <section id="v29657992" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v29657993" class="topic__header--section"> <span id="v29657993" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657996" class="anchor"></span><div class="para"> <p>Rheumatoid arthritis is a systemic inflammatory disorder.</p></div></li><li class="topic__listitem"><span id="v29657998" class="anchor"></span><div class="para"> <p>The most characteristic manifestation is a symmetric polyarthritis involving peripheral joints such as wrists and metacarpophalangeal and metatarsophalangeal joints, often with constitutional symptoms.</p></div></li><li class="topic__listitem"><span id="v29658000" class="anchor"></span><div class="para"> <p>Extra-articular findings can include rheumatoid nodules, vasculitis causing leg ulcers or multiple mononeuropathy, pleural or pericardial effusions, pulmonary nodules, pulmonary infiltrates or fibrosis, pericarditis, myocarditis, lymphadenopathy, Felty syndrome, Sjögren syndrome, scleromalacia, and episcleritis.</p></div></li><li class="topic__listitem"><span id="v29658002" class="anchor"></span><div class="para"> <p>X-rays are helpful, but early diagnosis is primarily by recognizing specific clinical findings and demonstrating abnormal laboratory test results, including autoantibodies (serum rheumatoid factor and anti-cyclic citrullinated peptide antibody) and acute-cell phase reactants (erythrocyte sedimentation rate or C-reactive protein). Diagnosis requires documented joint inflammation and should not be based on laboratory testing alone. </p></div></li><li class="topic__listitem"><span id="v29658004" class="anchor"></span><div class="para"> <p>Rheumatoid arthritis decreases life expectancy by 3 to 7 years (eg, due to gastrointestinal bleeding, infection, or coronary heart disease) and causes severe disability in 10% of patients.</p></div></li><li class="topic__listitem"><span id="v29658006" class="anchor"></span><div class="para"> <p>Treat almost all patients aggressively early, primarily with drugs that modify disease activity.</p></div></li><li class="topic__listitem"><span id="v29658008" class="anchor"></span><div class="para"> <p>Drugs that modify disease activity include traditional DMARDs (particularly <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methotrexate</span>), biologic agents such as tumor necrosis factor (TNF)-alpha antagonists or other non-TNF biologic agents, and other drugs that are immunomodulatory, cytotoxic, or immunosuppressive.</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="714.0;714.1;714.2;714.4;714.8">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '714.0;714.1;714.2;714.4;714.8',
 title: 'Rheumatoid Arthritis (RA)',
 itemGuid: '85563e6b-c6c5-4019-8939-abf04ba7bed4'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{9481812D-5690-4031-80FD-EC695FA4DDCA}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Osteoarthritis (OA)</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{94C0DF43-14D3-4BB9-9C6F-3E7445822E18}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Overview of Seronegative Spondyloarthropathies</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="3c995aad-1e5e-4e95-86c7-aa93605b954c_mobile" usemap="#3c995aad-1e5e-4e95-86c7-aa93605b954c_mobile" width="326" height="90">
 <map name="3c995aad-1e5e-4e95-86c7-aa93605b954c_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="3c995aad-1e5e-4e95-86c7-aa93605b954c_tablet" usemap="#3c995aad-1e5e-4e95-86c7-aa93605b954c_tablet" width="326" height="90">
 <map name="3c995aad-1e5e-4e95-86c7-aa93605b954c_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="3c995aad-1e5e-4e95-86c7-aa93605b954c_desktop" usemap="#3c995aad-1e5e-4e95-86c7-aa93605b954c_desktop" width="326" height="90">
 <map name="3c995aad-1e5e-4e95-86c7-aa93605b954c_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd04
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="85563E6BC6C540198939ABF04BA7BED4">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v29657258'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v29657259"></span> <div class="TableHalfPage" id="v29657258"> <h3 class="title">Classification Criteria for Rheumatoid Arthritis</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v29657266" class="anchor"></span><div class="para"> <p>Finding</p></div></th><th style='text-align:left' scope='col'><span id="v29657268" class="anchor"></span><div class="para"> <p>Score</p></div></th></tr></thead> <tbody><tr class="odd"><td colspan="2"><span id="v29657294" class="anchor"></span><div class="para"> <p>Criteria for evaluation:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657297" class="anchor"></span><div class="para"> <p>At least 1 joint with definite clinical synovitis (swelling)</p></div></li><li class="topic__listitem"><span id="v29657299" class="anchor"></span><div class="para"> <p>Synovitis not better explained by another disorder</p></div></li></ul></div><span id="v29657300" class="anchor"></span><div class="para"> <p>Classification criteria for rheumatoid arthritis is a score-based algorithm. Scores for categories A‒D are added; a score ≥ 6 (highest possible total 10) is needed to classify a patient as having definite rheumatoid arthritis.<sup>a</sup></p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v29657304" class="anchor"></span><div class="para"> <p>A. Joint involvement<sup>b</sup></p></div></p></td></tr><tr class="odd"><td><span id="v29657307" class="anchor"></span><div class="para"> <p>1 large joint<sup>c</sup></p></div></td><td><span id="v29657309" class="anchor"></span><div class="para"> <p>0</p></div></td></tr><tr class="even"><td><span id="v29657312" class="anchor"></span><div class="para"> <p>2‒10 large joints</p></div></td><td><span id="v29657314" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v29657317" class="anchor"></span><div class="para"> <p>1‒3 small joints<sup>d</sup> (with or without involvement of large joints)</p></div></td><td><span id="v29657319" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v29657322" class="anchor"></span><div class="para"> <p>4‒10 small joints (with or without involvement of large joints)</p></div></td><td><span id="v29657324" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v29657327" class="anchor"></span><div class="para"> <p>>10 joints<sup>e</sup> (at least 1 small joint)</p></div></td><td><span id="v29657329" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v29657333" class="anchor"></span><div class="para"> <p>B. Serology (at least 1 test result is needed for classification)</p></div></p></td></tr><tr class="odd"><td><span id="v29657336" class="anchor"></span><div class="para"> <p>Negative RF and negative anti-CCP</p></div></td><td><span id="v29657338" class="anchor"></span><div class="para"> <p>0</p></div></td></tr><tr class="even"><td><span id="v29657341" class="anchor"></span><div class="para"> <p>Low-positive<sup>f</sup> RF or low-positive anti-CCP</p></div></td><td><span id="v29657343" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v29657346" class="anchor"></span><div class="para"> <p>High-positive<sup>g</sup> RF or high-positive anti-CCP</p></div></td><td><span id="v29657348" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v29657352" class="anchor"></span><div class="para"> <p>C. Acute-phase reactants (at least 1 test result is needed for classification)</p></div></p></td></tr><tr class="odd"><td><span id="v29657355" class="anchor"></span><div class="para"> <p>Normal CRP and normal erythrocyte sedimentation rate</p></div></td><td><span id="v29657357" class="anchor"></span><div class="para"> <p>0</p></div></td></tr><tr class="even"><td><span id="v29657360" class="anchor"></span><div class="para"> <p>Abnormal CRP or abnormal erythrocyte sedimentation rate</p></div></td><td><span id="v29657362" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v29657366" class="anchor"></span><div class="para"> <p>D. Duration of symptoms (based on patient's report)</p></div></p></td></tr><tr class="even"><td><span id="v29657369" class="anchor"></span><div class="para"> <p>< 6></p></div></td><td><span id="v29657371" class="anchor"></span><div class="para"> <p>0</p></div></td></tr><tr class="odd"><td><span id="v29657374" class="anchor"></span><div class="para"> <p>≥ 6 weeks</p></div></td><td><span id="v29657376" class="anchor"></span><div class="para"> <p>1</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v29657272" class="anchor"></span><div class="para"> <p><sup>a</sup> Patients with a score of < 6 can be reassessed; they may meet the criteria for rheumatoid arthritis cumulatively over></p></div></td></tr><tr><td colspan="2"><span id="v29657275" class="anchor"></span><div class="para"> <p><sup>b </sup>Distal interphalangeal joints, first carpometacarpal joints, and first metatarsophalangeal joints are excluded from assessment. </p></div></td></tr><tr><td colspan="2"><span id="v29657278" class="anchor"></span><div class="para"> <p><sup>c</sup> Large joints are the shoulders, elbows, hips, knees, and ankles.</p></div></td></tr><tr><td colspan="2"><span id="v29657281" class="anchor"></span><div class="para"> <p><sup>d</sup> Small joints are the metacarpophalangeal joints, proximal interphalangeal joints, 2nd‒5th metatarsophalangeal joints, thumb interphalangeal joints, and wrists.</p></div></td></tr><tr><td colspan="2"><span id="v29657284" class="anchor"></span><div class="para"> <p><sup>e</sup> These joints may include other joints not specifically listed elsewhere (eg, temporomandibular, acromioclavicular, sternoclavicular).</p></div></td></tr><tr><td colspan="2"><span id="v41326903" class="anchor"></span><div class="para"> <p><sup>f</sup> Low positive indicates levels between 1 and 3 times the upper limit of normal.</p></div></td></tr><tr><td colspan="2"><span id="v41326906" class="anchor"></span><div class="para"> <p><sup>g</sup> High positive indicates levels at least 3 times the upper limit of normal.</p></div></td></tr><tr><td colspan="2"><span id="v29657287" class="anchor"></span><div class="para"> <p>Anti-CCP = anticitrullinated protein antibody; CRP = C-reactive protein; RF = rheumatoid factor.</p></div></td></tr><tr><td colspan="2"><span id="v29657290" class="anchor"></span><div class="para"> <p>Adapted from Aletaha D, Neogi T, Silman AJ, et al: 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. <i>Arthritis Rheum</i> 62 (9):2569–2581, 2010.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v29657517'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v29657518"></span> <div class="TableFullPage" id="v29657517"> <h3 class="title">Nonsteroidal Anti-inflammatory Drug (NSAID) Treatment of Rheumatoid Arthritis</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657527" class="anchor"></span><div class="para"> <p>Drug</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657530" class="anchor"></span><div class="para"> <p>Usual Dosage (Oral)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657533" class="anchor"></span><div class="para"> <p>Maximum Recommended Daily Dose</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657545" class="anchor"></span><div class="para"> <p>Nonselective NSAIDs</p></div></p></td></tr><tr class="even"><td><span id="v29657548" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Diclofenac</span></p></div></td><td><span id="v29657550" class="anchor"></span><div class="para"> <p>75 mg 2 times a day or 50 mg 3 times a day</p></div><span id="v29657551" class="anchor"></span><div class="para"> <p>100 mg once/day sustained-release</p></div></td><td><span id="v29657553" class="anchor"></span><div class="para"> <p>150 mg</p></div></td></tr><tr class="odd"><td><span id="v29657556" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Etodolac</span></p></div></td><td><span id="v29657558" class="anchor"></span><div class="para"> <p>300–500 mg 2 times a day</p></div></td><td><span id="v29657560" class="anchor"></span><div class="para"> <p>1200 mg</p></div></td></tr><tr class="even"><td><span id="v29657563" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fenoprofen</span></p></div></td><td><span id="v29657565" class="anchor"></span><div class="para"> <p>300–600 mg 4 times a day</p></div></td><td><span id="v29657567" class="anchor"></span><div class="para"> <p>3200 mg</p></div></td></tr><tr class="odd"><td><span id="v29657570" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Flurbiprofen</span></p></div></td><td><span id="v29657572" class="anchor"></span><div class="para"> <p>100 mg 2 or 3 times a day </p></div></td><td><span id="v29657574" class="anchor"></span><div class="para"> <p>300 mg</p></div></td></tr><tr class="even"><td><span id="v29657577" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ibuprofen</span></p></div></td><td><span id="v29657579" class="anchor"></span><div class="para"> <p>400–800 mg 4 times a day</p></div></td><td><span id="v29657581" class="anchor"></span><div class="para"> <p>3200 mg</p></div></td></tr><tr class="odd"><td><span id="v29657584" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Indomethacin</span></p></div></td><td><span id="v29657586" class="anchor"></span><div class="para"> <p>25 mg 3 to 4 times a day</p></div><span id="v29657587" class="anchor"></span><div class="para"> <p>75 mg 2 times a day sustained-release</p></div></td><td><span id="v29657589" class="anchor"></span><div class="para"> <p>200 mg</p></div></td></tr><tr class="even"><td><span id="v29657592" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ketoprofen</span></p></div></td><td><span id="v29657594" class="anchor"></span><div class="para"> <p>50–75 mg 4 times a day</p></div><span id="v29657595" class="anchor"></span><div class="para"> <p>200 mg once/day sustained-release</p></div></td><td><span id="v29657597" class="anchor"></span><div class="para"> <p>300 mg</p></div></td></tr><tr class="odd"><td><span id="v29657600" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Meclofenamate</p></div></td><td><span id="v29657602" class="anchor"></span><div class="para"> <p>50 mg 3 or 4 times a day</p></div></td><td><span id="v29657604" class="anchor"></span><div class="para"> <p>400 mg</p></div></td></tr><tr class="even"><td><span id="v41326912" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Meloxicam</span>*</p></div></td><td><span id="v41326914" class="anchor"></span><div class="para"> <p>7.5 mg once/day</p></div></td><td><span id="v41326916" class="anchor"></span><div class="para"> <p>15 mg</p></div></td></tr><tr class="odd"><td><span id="v29657607" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nabumetone</span></p></div></td><td><span id="v29657609" class="anchor"></span><div class="para"> <p>1000–2000 mg/day in 1 dosage or in divided dosages (500–1000 mg 2 times a day)</p></div></td><td><span id="v29657611" class="anchor"></span><div class="para"> <p>2000 mg</p></div></td></tr><tr class="even"><td><span id="v29657614" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Naproxen</span></p></div></td><td><span id="v29657616" class="anchor"></span><div class="para"> <p>250–500 mg 2 times a day</p></div></td><td><span id="v29657618" class="anchor"></span><div class="para"> <p>1500 mg</p></div></td></tr><tr class="odd"><td><span id="v29657621" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Oxaprozin</span></p></div></td><td><span id="v29657623" class="anchor"></span><div class="para"> <p>1200 mg once/day</p></div></td><td><span id="v29657625" class="anchor"></span><div class="para"> <p>1800 mg</p></div></td></tr><tr class="even"><td><span id="v29657628" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Piroxicam</span></p></div></td><td><span id="v29657630" class="anchor"></span><div class="para"> <p>20 mg once/day</p></div></td><td><span id="v29657632" class="anchor"></span><div class="para"> <p>20 mg</p></div></td></tr><tr class="odd"><td><span id="v29657635" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sulindac</span></p></div></td><td><span id="v29657637" class="anchor"></span><div class="para"> <p>150–200 mg 2 times a day</p></div></td><td><span id="v29657639" class="anchor"></span><div class="para"> <p>400 mg</p></div></td></tr><tr class="even"><td><span id="v29657642" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tolmetin</span></p></div></td><td><span id="v29657644" class="anchor"></span><div class="para"> <p>400 mg 3 times a day</p></div></td><td><span id="v29657646" class="anchor"></span><div class="para"> <p>1800 mg</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657650" class="anchor"></span><div class="para"> <p>Cyclooxygenase-2 (COX-2) selective NSAIDs</p></div></p></td></tr><tr class="even"><td><span id="v29657653" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Celecoxib</span></p></div></td><td><span id="v29657655" class="anchor"></span><div class="para"> <p>200 mg once/day or 2 times a day</p></div></td><td><span id="v29657657" class="anchor"></span><div class="para"> <p>400 mg</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v29657537" class="anchor"></span><div class="para"> <p>*COX-2 specificity of this drug is unclear.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v29657694'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v29657695"></span> <div class="TableHalfPage" id="v29657694"> <h3 class="title">Other Drugs Used to Treat Rheumatoid Arthritis</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657704" class="anchor"></span><div class="para"> <p>Drug</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657707" class="anchor"></span><div class="para"> <p>Dosage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657710" class="anchor"></span><div class="para"> <p>Adverse Effects</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657728" class="anchor"></span><div class="para"> <p>Traditional disease-modifying antirheumatic drugs (DMARDs)</p></div></p></td></tr><tr class="even"><td><span id="v29657731" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span></p></div></td><td><span id="v29657733" class="anchor"></span><div class="para"> <p>5 mg/kg orally once/day (eg, with breakfast or dinner) or in 2 divided dosages (eg, 2.5 mg every 12 hours)</p></div></td><td><span id="v29657736" class="anchor"></span><div class="para"> <p>Usually mild dermatitis</p></div><span id="v29657737" class="anchor"></span><div class="para"> <p>Rarely, myopathy or cardiomyopathy</p></div><span id="v29657738" class="anchor"></span><div class="para"> <p>Corneal opacity (generally reversible)</p></div><span id="v29657739" class="anchor"></span><div class="para"> <p>Rarely, irreversible retinal degeneration</p></div></td></tr><tr class="odd"><td><span id="v29657742" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Leflunomide</span></p></div></td><td><span id="v29657744" class="anchor"></span><div class="para"> <p>20 mg orally once/day or, if adverse effects occur, reduced to 10 mg once/day</p></div></td><td><span id="v29657746" class="anchor"></span><div class="para"> <p>Skin reactions</p></div><span id="v29657747" class="anchor"></span><div class="para"> <p>Hepatic dysfunction</p></div><span id="v29657748" class="anchor"></span><div class="para"> <p>Alopecia</p></div><span id="v29657749" class="anchor"></span><div class="para"> <p>Diarrhea</p></div><span id="v41326920" class="anchor"></span><div class="para"> <p>Peripheral neuropathy</p></div><span id="x000104" class="anchor"></span><div class="para"> <p>Teratogenicity</p></div></td></tr><tr class="even"><td><span id="v29657752" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Methotrexate</span></p></div></td><td><span id="v29657754" class="anchor"></span><div class="para"> <p>Single oral dose once/week, starting at 10 to 15 mg and gradually increased as needed to a maximum of 25 mg</p></div><span id="v29657755" class="anchor"></span><div class="para"> <p>Doses <span class='symbol'>></span> 20 mg/week best given subcutaneously to ensure bioavailability (or split into 2 oral doses separated by 12 hours)</p></div></td><td><span id="v29657757" class="anchor"></span><div class="para"> <p>Liver fibrosis (dose-related, often reversible)</p></div><span id="v29657758" class="anchor"></span><div class="para"> <p>Nausea </p></div><span id="v41326921" class="anchor"></span><div class="para"> <p>Malaise</p></div><span id="v29657759" class="anchor"></span><div class="para"> <p>Bone marrow suppression</p></div><span id="v29657760" class="anchor"></span><div class="para"> <p>Stomatitis</p></div><span id="v29657761" class="anchor"></span><div class="para"> <p>Rarely, pneumonitis </p></div><span id="x000105" class="anchor"></span><div class="para"> <p>Teratogenicity, abortifacient effect</p></div></td></tr><tr class="odd"><td><span id="v29657764" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sulfasalazine</span>*</p></div></td><td><span id="v29657766" class="anchor"></span><div class="para"> <p>500 mg orally in the evening, increased to 500 mg in the morning and 1000 mg in the evening, then increased to 1000–1500 mg 2 times a day</p></div></td><td><span id="v29657768" class="anchor"></span><div class="para"> <p>Bone marrow suppression</p></div><span id="v29657769" class="anchor"></span><div class="para"> <p>Gastric symptoms</p></div><span id="v29657770" class="anchor"></span><div class="para"> <p>Neutropenia (usually on initiation of treatment)</p></div><span id="v29657771" class="anchor"></span><div class="para"> <p>Hemolysis</p></div><span id="v29657772" class="anchor"></span><div class="para"> <p>Hepatitis</p></div><span id="x000069" class="anchor"></span><div class="para"> <p>Reversible oligospermia</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657776" class="anchor"></span><div class="para"> <p>Corticosteroids, intra-articular injections</p></div></p></td></tr><tr class="odd"><td><span id="v29657779" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Methylprednisolone</span> acetate</p></div></td><td><span id="v29657781" class="anchor"></span><div class="para"> <p>Depends on the joint</p></div></td><td rowspan="3"><span id="v29657783" class="anchor"></span><div class="para"> <p>With long-term use: Rarely infection at the injection site</p></div></td></tr><tr class="even"><td><span id="v29657786" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Triamcinolone</span> acetonide</p></div></td><td><span id="v29657788" class="anchor"></span><div class="para"> <p>Depends on the joint</p></div></td></tr><tr class="odd"><td><span id="v29657791" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Triamcinolone</span> hexacetonide</p></div></td><td><span id="v29657793" class="anchor"></span><div class="para"> <p>10–40 mg, depending on the joint </p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657797" class="anchor"></span><div class="para"> <p>Corticosteroids, systemic</p></div></p></td></tr><tr class="odd"><td><span id="v29657800" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Prednisone</span></p></div><span id="v29657801" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Prednisolone</span></p></div></td><td><span id="v29657803" class="anchor"></span><div class="para"> <p>Attempts should be made to avoid exceeding 7.5 mg orally once/day (except in patients with severe systemic manifestations)</p></div></td><td><span id="v29657805" class="anchor"></span><div class="para"> <p>With long-term use: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657808" class="anchor"></span><div class="para"> <p>Weight gain</p></div></li><li class="topic__listitem"><span id="v29657810" class="anchor"></span><div class="para"> <p>Diabetes</p></div></li><li class="topic__listitem"><span id="v29657812" class="anchor"></span><div class="para"> <p>Hypertension</p></div></li><li class="topic__listitem"><span id="v29657814" class="anchor"></span><div class="para"> <p>Osteoporosis, osteonecrosis </p></div></li><li class="topic__listitem"><span id="v41326923" class="anchor"></span><div class="para"> <p>Cataracts</p></div></li><li class="topic__listitem"><span id="x000205" class="anchor"></span><div class="para"> <p>Candidiasis</p></div></li></ul></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657837" class="anchor"></span><div class="para"> <p>Biologic agents</p></div></p></td></tr><tr class="odd"><td><span id="v29657840" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Abatacept</span></p></div></td><td><span id="v29657842" class="anchor"></span><div class="para"> <p>Initially an IV loading dose of 500 mg IV for patients weighing < 60="" kg,="" 750="" mg="" iv="" for="" patients="" weighing="" 60–100="" kg,="" and="" 1="" g="" iv="" for="" patients="" weighing=""> 100 kg, then same dose on weeks 2 and 4 later, and then every 4 weeks</p></div><span id="v29657843" class="anchor"></span><div class="para"> <p><i>or</i></p></div><span id="v29657844" class="anchor"></span><div class="para"> <p>125 mg subcutaneously once/week with or without one IV loading dose 1 week previously</p></div></td><td><span id="v29657846" class="anchor"></span><div class="para"> <p>Pulmonary toxicity</p></div><span id="v29657847" class="anchor"></span><div class="para"> <p>Susceptibility to infection</p></div><span id="v29657848" class="anchor"></span><div class="para"> <p>Headache</p></div><span id="v29657849" class="anchor"></span><div class="para"> <p>Upper respiratory infection</p></div><span id="v29657850" class="anchor"></span><div class="para"> <p>Sore throat</p></div><span id="v29657851" class="anchor"></span><div class="para"> <p>Nausea</p></div></td></tr><tr class="even"><td><span id="v29657854" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rituximab</span></p></div></td><td><span id="v29657856" class="anchor"></span><div class="para"> <p>1 g IV at baseline and at 2 weeks (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methylprednisolone</span> 60–125 mg IV is given with each dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rituximab</span> to prevent hypersensitivity reactions)</p></div></td><td><span id="v29657858" class="anchor"></span><div class="para"> <p>When the drug is being given:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657861" class="anchor"></span><div class="para"> <p>Mild itching at the injection site</p></div></li><li class="topic__listitem"><span id="v29657863" class="anchor"></span><div class="para"> <p>Rashes</p></div></li><li class="topic__listitem"><span id="v29657865" class="anchor"></span><div class="para"> <p>Back pain</p></div></li><li class="topic__listitem"><span id="v29657867" class="anchor"></span><div class="para"> <p>Hypertension or hypotension</p></div></li><li class="topic__listitem"><span id="v29657869" class="anchor"></span><div class="para"> <p>Fever</p></div></li></ul></div><span id="v29657870" class="anchor"></span><div class="para"> <p>After the drug is given: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657873" class="anchor"></span><div class="para"> <p>Increased risk of infection and possibly cancer</p></div></li><li class="topic__listitem"><span id="v29657875" class="anchor"></span><div class="para"> <p>Hypogammaglobulinemia</p></div></li><li class="topic__listitem"><span id="v29657877" class="anchor"></span><div class="para"> <p>Neutropenia</p></div></li><li class="topic__listitem"><span id="v41326926" class="anchor"></span><div class="para"> <p>Reactivation of hepatitis B with hepatic necrosis</p></div></li></ul></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v41326932" class="anchor"></span><div class="para"> <p>Interleukin-6 (IL-6) inhibitors‡</p></div></p></td></tr><tr class="even"><td><span id="v41326935" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sarilumab</span></p></div></td><td><span id="v41326937" class="anchor"></span><div class="para"> <p>200 mg subcutaneously once every 2 weeks</p></div><span id="v41326938" class="anchor"></span><div class="para"> <p>Dosage can be reduced to 150 mg once every 2 weeks</p></div></td><td><span id="v41326940" class="anchor"></span><div class="para"> <p>Neutropenia</p></div><span id="v41326941" class="anchor"></span><div class="para"> <p>Thrombocytopenia</p></div><span id="v41326942" class="anchor"></span><div class="para"> <p>Transaminase elevation</p></div></td></tr><tr class="odd"><td><span id="v41326945" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tocilizumab</span> </p></div></td><td><span id="v41326947" class="anchor"></span><div class="para"> <p>8 mg/kg IV every 4 weeks, to a maximum 800 mg/dose</p></div><span id="v41326948" class="anchor"></span><div class="para"> <p><i>or</i></p></div><span id="v41326949" class="anchor"></span><div class="para"> <p>162 mg subcutaneously every other week followed by an increase to every week based on clinical response in patients weighing < 100="" kg=""></p></div><span id="v41326950" class="anchor"></span><div class="para"> <p>162 mg subcutaneously every week in patients weighing > 100 kg</p></div></td><td><span id="v41326952" class="anchor"></span><div class="para"> <p>Potential risk of infection (particularly opportunistic organisms) </p></div><span id="v41326953" class="anchor"></span><div class="para"> <p>Neutropenia</p></div><span id="v41326954" class="anchor"></span><div class="para"> <p>Thrombocytopenia</p></div><span id="v41326955" class="anchor"></span><div class="para"> <p>Gastrointestinal perforation</p></div><span id="v41326956" class="anchor"></span><div class="para"> <p>Anaphylaxis</p></div><span id="v41326957" class="anchor"></span><div class="para"> <p>Transaminase elevation</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657881" class="anchor"></span><div class="para"> <p>Interleukin-1 (IL-1) receptor inhibitor‡</p></div></p></td></tr><tr class="odd"><td><span id="v29657884" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Anakinra</span></p></div></td><td><span id="v29657886" class="anchor"></span><div class="para"> <p>100 mg subcutaneously once/day</p></div></td><td><span id="v29657888" class="anchor"></span><div class="para"> <p>Injection site reactions</p></div><span id="v29657889" class="anchor"></span><div class="para"> <p>Immunosuppression</p></div><span id="v29657890" class="anchor"></span><div class="para"> <p>Neutropenia</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657909" class="anchor"></span><div class="para"> <p>Tumor necrosis factor (TNF)-alpha antagonists‡</p></div></p></td></tr><tr class="odd"><td><span id="v29657912" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span></p></div><span id="v48477189" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-atto</p></div><span id="v48477190" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-adbm </p></div><span id="v48477191" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-adaz </p></div><span id="v48477192" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-bwwd</p></div><span id="v48477193" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-afzb</p></div></td><td><span id="v29657914" class="anchor"></span><div class="para"> <p>40 mg subcutaneously once every 2 weeks</p></div></td><td rowspan="5"><span id="v29657916" class="anchor"></span><div class="para"> <p>Potential risk of reactivation of infection (particularly tuberculosis and fungal infections) </p></div><span id="v41326958" class="anchor"></span><div class="para"> <p>Reactivation of hepatitis B</p></div><span id="v29657917" class="anchor"></span><div class="para"> <p>Nonmelanoma skin cancers</p></div><span id="v29657919" class="anchor"></span><div class="para"> <p>Antinuclear antibodies with or without clinical systemic lupus erythematosus (SLE)</p></div><span id="v29657920" class="anchor"></span><div class="para"> <p>Demyelinating neurologic disorders</p></div><span id="v41326959" class="anchor"></span><div class="para"> <p>Heart failure worsening</p></div></td></tr><tr class="even"><td><span id="v29657923" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Certolizumab pegol</span></p></div></td><td><span id="v29657925" class="anchor"></span><div class="para"> <p>400 mg subcutaneously (as 2 subcutaneous injections of 200 mg) once and then repeat at week 2 and week 4, followed by 200 mg subcutaneously every 2 weeks (or 400 mg subcutaneously every 4 weeks)</p></div></td></tr><tr class="odd"><td><span id="v29657928" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Etanercept</span></p></div><span id="v48477194" class="anchor"></span><div class="para"> <p><b>Biosimilars:</b></p></div><span id="v29657929" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Etanercept</span>-szzs </p></div><span id="v48477195" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Etanercept</span>-ykro</p></div></td><td><span id="v29657931" class="anchor"></span><div class="para"> <p>50 mg subcutaneously once/week</p></div></td></tr><tr class="even"><td><span id="v29657934" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Golimumab</span></p></div></td><td><span id="v29657936" class="anchor"></span><div class="para"> <p>50 mg subcutaneously once every 4 weeks</p></div></td></tr><tr class="odd"><td><span id="v29657939" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span></p></div><span id="v48477196" class="anchor"></span><div class="para"> <p><b>Biosimilars:</b></p></div><span id="v29657940" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span>-dyyb</p></div><span id="v48477197" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span>-abda</p></div><span id="v48477198" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span>-qbtx</p></div><span id="v48477199" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span>-axxq</p></div></td><td><span id="v29657942" class="anchor"></span><div class="para"> <p>3-mg/kg IV infusion in saline at baseline, at 2 weeks, and at 6 weeks with subsequent injections every 8 weeks (dosage may be increased to 10 mg/kg)</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657946" class="anchor"></span><div class="para"> <p>Janus kinase (JAK) inhibitors‡</p></div></p></td></tr><tr class="odd"><td><span id="v41326960" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Baricitinib</span></p></div></td><td><span id="v41326961" class="anchor"></span><div class="para"> <p>2 mg orally once/day</p></div></td><td><span id="v29657953" class="anchor"></span><div class="para"> <p>Risk of infection, particularly varicella-zoster virus reactivation</p></div><span id="v29657954" class="anchor"></span><div class="para"> <p>Nonmelanoma skin cancers</p></div><span id="v29657955" class="anchor"></span><div class="para"> <p>Hypercholesterolemia</p></div><span id="v41326962" class="anchor"></span><div class="para"> <p>Venous thromboembolism</p></div><span id="x000068" class="anchor"></span><div class="para"> <p>Major adverse cardiovascular events</p></div><span id="x000115" class="anchor"></span><div class="para"> <p>Lung cancer</p></div></td></tr><tr class="even"><td><span id="v41326965" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tofacitinib</span></p></div></td><td><span id="v41326967" class="anchor"></span><div class="para"> <p>5 mg orally 2 times a day</p></div></td><td><span id="v41326969" class="anchor"></span><div class="para"> <p>Risk of infection, particularly varicella-zoster virus reactivation</p></div><span id="v41326970" class="anchor"></span><div class="para"> <p>Nonmelanoma skin cancers</p></div><span id="v41326971" class="anchor"></span><div class="para"> <p>Hypercholesterolemia</p></div><span id="v48477200" class="anchor"></span><div class="para"> <p>Venous thromboembolism</p></div><span id="x000067" class="anchor"></span><div class="para"> <p>Major adverse cardiovascular events </p></div><span id="x000116" class="anchor"></span><div class="para"> <p>Lung cancer</p></div></td></tr><tr class="odd"><td><span id="v48477203" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Upadacitinib</span> </p></div></td><td><span id="v48477205" class="anchor"></span><div class="para"> <p>15 mg orally once/day</p></div></td><td><span id="v48477207" class="anchor"></span><div class="para"> <p>Risk of infection, particularly varicella-zoster virus reactivation </p></div><span id="v48477208" class="anchor"></span><div class="para"> <p>Nonmelanoma skin cancers </p></div><span id="v48477209" class="anchor"></span><div class="para"> <p>Hypercholesterolemia </p></div><span id="v48477210" class="anchor"></span><div class="para"> <p>Venous thromboembolism</p></div><span id="x000066" class="anchor"></span><div class="para"> <p>Major adverse cardiovascular events</p></div><span id="x000117" class="anchor"></span><div class="para"> <p>Lung cancer</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v29657714" class="anchor"></span><div class="para"> <p>* <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sulfasalazine</span> is usually given as enteric-coated tablets.</p></div></td></tr><tr><td colspan="3"><span id="v29657717" class="anchor"></span><div class="para"> <p>† During dosage increases for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>azathioprine</span>, complete blood count, aspartate aminotransferase, and alanine aminotransferase are monitored.</p></div></td></tr><tr><td colspan="3"><span id="v29657720" class="anchor"></span><div class="para"> <p>‡ These drugs are biologic agents.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v29657258'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v29657259"></span> <div class="TableHalfPage" id="v29657258"> <h3 class="title">Classification Criteria for Rheumatoid Arthritis</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v29657266" class="anchor"></span><div class="para"> <p>Finding</p></div></th><th style='text-align:left' scope='col'><span id="v29657268" class="anchor"></span><div class="para"> <p>Score</p></div></th></tr></thead> <tbody><tr class="odd"><td colspan="2"><span id="v29657294" class="anchor"></span><div class="para"> <p>Criteria for evaluation:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657297" class="anchor"></span><div class="para"> <p>At least 1 joint with definite clinical synovitis (swelling)</p></div></li><li class="topic__listitem"><span id="v29657299" class="anchor"></span><div class="para"> <p>Synovitis not better explained by another disorder</p></div></li></ul></div><span id="v29657300" class="anchor"></span><div class="para"> <p>Classification criteria for rheumatoid arthritis is a score-based algorithm. Scores for categories A‒D are added; a score ≥ 6 (highest possible total 10) is needed to classify a patient as having definite rheumatoid arthritis.<sup>a</sup></p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v29657304" class="anchor"></span><div class="para"> <p>A. Joint involvement<sup>b</sup></p></div></p></td></tr><tr class="odd"><td><span id="v29657307" class="anchor"></span><div class="para"> <p>1 large joint<sup>c</sup></p></div></td><td><span id="v29657309" class="anchor"></span><div class="para"> <p>0</p></div></td></tr><tr class="even"><td><span id="v29657312" class="anchor"></span><div class="para"> <p>2‒10 large joints</p></div></td><td><span id="v29657314" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v29657317" class="anchor"></span><div class="para"> <p>1‒3 small joints<sup>d</sup> (with or without involvement of large joints)</p></div></td><td><span id="v29657319" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="even"><td><span id="v29657322" class="anchor"></span><div class="para"> <p>4‒10 small joints (with or without involvement of large joints)</p></div></td><td><span id="v29657324" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="odd"><td><span id="v29657327" class="anchor"></span><div class="para"> <p>>10 joints<sup>e</sup> (at least 1 small joint)</p></div></td><td><span id="v29657329" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v29657333" class="anchor"></span><div class="para"> <p>B. Serology (at least 1 test result is needed for classification)</p></div></p></td></tr><tr class="odd"><td><span id="v29657336" class="anchor"></span><div class="para"> <p>Negative RF and negative anti-CCP</p></div></td><td><span id="v29657338" class="anchor"></span><div class="para"> <p>0</p></div></td></tr><tr class="even"><td><span id="v29657341" class="anchor"></span><div class="para"> <p>Low-positive<sup>f</sup> RF or low-positive anti-CCP</p></div></td><td><span id="v29657343" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v29657346" class="anchor"></span><div class="para"> <p>High-positive<sup>g</sup> RF or high-positive anti-CCP</p></div></td><td><span id="v29657348" class="anchor"></span><div class="para"> <p>3</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v29657352" class="anchor"></span><div class="para"> <p>C. Acute-phase reactants (at least 1 test result is needed for classification)</p></div></p></td></tr><tr class="odd"><td><span id="v29657355" class="anchor"></span><div class="para"> <p>Normal CRP and normal erythrocyte sedimentation rate</p></div></td><td><span id="v29657357" class="anchor"></span><div class="para"> <p>0</p></div></td></tr><tr class="even"><td><span id="v29657360" class="anchor"></span><div class="para"> <p>Abnormal CRP or abnormal erythrocyte sedimentation rate</p></div></td><td><span id="v29657362" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v29657366" class="anchor"></span><div class="para"> <p>D. Duration of symptoms (based on patient's report)</p></div></p></td></tr><tr class="even"><td><span id="v29657369" class="anchor"></span><div class="para"> <p>< 6=""></p></div></td><td><span id="v29657371" class="anchor"></span><div class="para"> <p>0</p></div></td></tr><tr class="odd"><td><span id="v29657374" class="anchor"></span><div class="para"> <p>≥ 6 weeks</p></div></td><td><span id="v29657376" class="anchor"></span><div class="para"> <p>1</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v29657272" class="anchor"></span><div class="para"> <p><sup>a</sup> Patients with a score of < 6="" can="" be="" reassessed;="" they="" may="" meet="" the="" criteria="" for="" rheumatoid="" arthritis="" cumulatively="" over=""></p></div></td></tr><tr><td colspan="2"><span id="v29657275" class="anchor"></span><div class="para"> <p><sup>b </sup>Distal interphalangeal joints, first carpometacarpal joints, and first metatarsophalangeal joints are excluded from assessment. </p></div></td></tr><tr><td colspan="2"><span id="v29657278" class="anchor"></span><div class="para"> <p><sup>c</sup> Large joints are the shoulders, elbows, hips, knees, and ankles.</p></div></td></tr><tr><td colspan="2"><span id="v29657281" class="anchor"></span><div class="para"> <p><sup>d</sup> Small joints are the metacarpophalangeal joints, proximal interphalangeal joints, 2nd‒5th metatarsophalangeal joints, thumb interphalangeal joints, and wrists.</p></div></td></tr><tr><td colspan="2"><span id="v29657284" class="anchor"></span><div class="para"> <p><sup>e</sup> These joints may include other joints not specifically listed elsewhere (eg, temporomandibular, acromioclavicular, sternoclavicular).</p></div></td></tr><tr><td colspan="2"><span id="v41326903" class="anchor"></span><div class="para"> <p><sup>f</sup> Low positive indicates levels between 1 and 3 times the upper limit of normal.</p></div></td></tr><tr><td colspan="2"><span id="v41326906" class="anchor"></span><div class="para"> <p><sup>g</sup> High positive indicates levels at least 3 times the upper limit of normal.</p></div></td></tr><tr><td colspan="2"><span id="v29657287" class="anchor"></span><div class="para"> <p>Anti-CCP = anticitrullinated protein antibody; CRP = C-reactive protein; RF = rheumatoid factor.</p></div></td></tr><tr><td colspan="2"><span id="v29657290" class="anchor"></span><div class="para"> <p>Adapted from Aletaha D, Neogi T, Silman AJ, et al: 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. <i>Arthritis Rheum</i> 62 (9):2569–2581, 2010.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v29657694'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v29657695"></span> <div class="TableHalfPage" id="v29657694"> <h3 class="title">Other Drugs Used to Treat Rheumatoid Arthritis</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657704" class="anchor"></span><div class="para"> <p>Drug</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657707" class="anchor"></span><div class="para"> <p>Dosage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v29657710" class="anchor"></span><div class="para"> <p>Adverse Effects</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657728" class="anchor"></span><div class="para"> <p>Traditional disease-modifying antirheumatic drugs (DMARDs)</p></div></p></td></tr><tr class="even"><td><span id="v29657731" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span></p></div></td><td><span id="v29657733" class="anchor"></span><div class="para"> <p>5 mg/kg orally once/day (eg, with breakfast or dinner) or in 2 divided dosages (eg, 2.5 mg every 12 hours)</p></div></td><td><span id="v29657736" class="anchor"></span><div class="para"> <p>Usually mild dermatitis</p></div><span id="v29657737" class="anchor"></span><div class="para"> <p>Rarely, myopathy or cardiomyopathy</p></div><span id="v29657738" class="anchor"></span><div class="para"> <p>Corneal opacity (generally reversible)</p></div><span id="v29657739" class="anchor"></span><div class="para"> <p>Rarely, irreversible retinal degeneration</p></div></td></tr><tr class="odd"><td><span id="v29657742" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Leflunomide</span></p></div></td><td><span id="v29657744" class="anchor"></span><div class="para"> <p>20 mg orally once/day or, if adverse effects occur, reduced to 10 mg once/day</p></div></td><td><span id="v29657746" class="anchor"></span><div class="para"> <p>Skin reactions</p></div><span id="v29657747" class="anchor"></span><div class="para"> <p>Hepatic dysfunction</p></div><span id="v29657748" class="anchor"></span><div class="para"> <p>Alopecia</p></div><span id="v29657749" class="anchor"></span><div class="para"> <p>Diarrhea</p></div><span id="v41326920" class="anchor"></span><div class="para"> <p>Peripheral neuropathy</p></div><span id="x000104" class="anchor"></span><div class="para"> <p>Teratogenicity</p></div></td></tr><tr class="even"><td><span id="v29657752" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Methotrexate</span></p></div></td><td><span id="v29657754" class="anchor"></span><div class="para"> <p>Single oral dose once/week, starting at 10 to 15 mg and gradually increased as needed to a maximum of 25 mg</p></div><span id="v29657755" class="anchor"></span><div class="para"> <p>Doses <span class='symbol'>></span> 20 mg/week best given subcutaneously to ensure bioavailability (or split into 2 oral doses separated by 12 hours)</p></div></td><td><span id="v29657757" class="anchor"></span><div class="para"> <p>Liver fibrosis (dose-related, often reversible)</p></div><span id="v29657758" class="anchor"></span><div class="para"> <p>Nausea </p></div><span id="v41326921" class="anchor"></span><div class="para"> <p>Malaise</p></div><span id="v29657759" class="anchor"></span><div class="para"> <p>Bone marrow suppression</p></div><span id="v29657760" class="anchor"></span><div class="para"> <p>Stomatitis</p></div><span id="v29657761" class="anchor"></span><div class="para"> <p>Rarely, pneumonitis </p></div><span id="x000105" class="anchor"></span><div class="para"> <p>Teratogenicity, abortifacient effect</p></div></td></tr><tr class="odd"><td><span id="v29657764" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sulfasalazine</span>*</p></div></td><td><span id="v29657766" class="anchor"></span><div class="para"> <p>500 mg orally in the evening, increased to 500 mg in the morning and 1000 mg in the evening, then increased to 1000–1500 mg 2 times a day</p></div></td><td><span id="v29657768" class="anchor"></span><div class="para"> <p>Bone marrow suppression</p></div><span id="v29657769" class="anchor"></span><div class="para"> <p>Gastric symptoms</p></div><span id="v29657770" class="anchor"></span><div class="para"> <p>Neutropenia (usually on initiation of treatment)</p></div><span id="v29657771" class="anchor"></span><div class="para"> <p>Hemolysis</p></div><span id="v29657772" class="anchor"></span><div class="para"> <p>Hepatitis</p></div><span id="x000069" class="anchor"></span><div class="para"> <p>Reversible oligospermia</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657776" class="anchor"></span><div class="para"> <p>Corticosteroids, intra-articular injections</p></div></p></td></tr><tr class="odd"><td><span id="v29657779" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Methylprednisolone</span> acetate</p></div></td><td><span id="v29657781" class="anchor"></span><div class="para"> <p>Depends on the joint</p></div></td><td rowspan="3"><span id="v29657783" class="anchor"></span><div class="para"> <p>With long-term use: Rarely infection at the injection site</p></div></td></tr><tr class="even"><td><span id="v29657786" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Triamcinolone</span> acetonide</p></div></td><td><span id="v29657788" class="anchor"></span><div class="para"> <p>Depends on the joint</p></div></td></tr><tr class="odd"><td><span id="v29657791" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Triamcinolone</span> hexacetonide</p></div></td><td><span id="v29657793" class="anchor"></span><div class="para"> <p>10–40 mg, depending on the joint </p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657797" class="anchor"></span><div class="para"> <p>Corticosteroids, systemic</p></div></p></td></tr><tr class="odd"><td><span id="v29657800" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Prednisone</span></p></div><span id="v29657801" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Prednisolone</span></p></div></td><td><span id="v29657803" class="anchor"></span><div class="para"> <p>Attempts should be made to avoid exceeding 7.5 mg orally once/day (except in patients with severe systemic manifestations)</p></div></td><td><span id="v29657805" class="anchor"></span><div class="para"> <p>With long-term use: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657808" class="anchor"></span><div class="para"> <p>Weight gain</p></div></li><li class="topic__listitem"><span id="v29657810" class="anchor"></span><div class="para"> <p>Diabetes</p></div></li><li class="topic__listitem"><span id="v29657812" class="anchor"></span><div class="para"> <p>Hypertension</p></div></li><li class="topic__listitem"><span id="v29657814" class="anchor"></span><div class="para"> <p>Osteoporosis, osteonecrosis </p></div></li><li class="topic__listitem"><span id="v41326923" class="anchor"></span><div class="para"> <p>Cataracts</p></div></li><li class="topic__listitem"><span id="x000205" class="anchor"></span><div class="para"> <p>Candidiasis</p></div></li></ul></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657837" class="anchor"></span><div class="para"> <p>Biologic agents</p></div></p></td></tr><tr class="odd"><td><span id="v29657840" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Abatacept</span></p></div></td><td><span id="v29657842" class="anchor"></span><div class="para"> <p>Initially an IV loading dose of 500 mg IV for patients weighing < 60="" kg,="" 750="" mg="" iv="" for="" patients="" weighing="" 60–100="" kg,="" and="" 1="" g="" iv="" for="" patients="" weighing=""> 100 kg, then same dose on weeks 2 and 4 later, and then every 4 weeks</p></div><span id="v29657843" class="anchor"></span><div class="para"> <p><i>or</i></p></div><span id="v29657844" class="anchor"></span><div class="para"> <p>125 mg subcutaneously once/week with or without one IV loading dose 1 week previously</p></div></td><td><span id="v29657846" class="anchor"></span><div class="para"> <p>Pulmonary toxicity</p></div><span id="v29657847" class="anchor"></span><div class="para"> <p>Susceptibility to infection</p></div><span id="v29657848" class="anchor"></span><div class="para"> <p>Headache</p></div><span id="v29657849" class="anchor"></span><div class="para"> <p>Upper respiratory infection</p></div><span id="v29657850" class="anchor"></span><div class="para"> <p>Sore throat</p></div><span id="v29657851" class="anchor"></span><div class="para"> <p>Nausea</p></div></td></tr><tr class="even"><td><span id="v29657854" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rituximab</span></p></div></td><td><span id="v29657856" class="anchor"></span><div class="para"> <p>1 g IV at baseline and at 2 weeks (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>methylprednisolone</span> 60–125 mg IV is given with each dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rituximab</span> to prevent hypersensitivity reactions)</p></div></td><td><span id="v29657858" class="anchor"></span><div class="para"> <p>When the drug is being given:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657861" class="anchor"></span><div class="para"> <p>Mild itching at the injection site</p></div></li><li class="topic__listitem"><span id="v29657863" class="anchor"></span><div class="para"> <p>Rashes</p></div></li><li class="topic__listitem"><span id="v29657865" class="anchor"></span><div class="para"> <p>Back pain</p></div></li><li class="topic__listitem"><span id="v29657867" class="anchor"></span><div class="para"> <p>Hypertension or hypotension</p></div></li><li class="topic__listitem"><span id="v29657869" class="anchor"></span><div class="para"> <p>Fever</p></div></li></ul></div><span id="v29657870" class="anchor"></span><div class="para"> <p>After the drug is given: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29657873" class="anchor"></span><div class="para"> <p>Increased risk of infection and possibly cancer</p></div></li><li class="topic__listitem"><span id="v29657875" class="anchor"></span><div class="para"> <p>Hypogammaglobulinemia</p></div></li><li class="topic__listitem"><span id="v29657877" class="anchor"></span><div class="para"> <p>Neutropenia</p></div></li><li class="topic__listitem"><span id="v41326926" class="anchor"></span><div class="para"> <p>Reactivation of hepatitis B with hepatic necrosis</p></div></li></ul></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v41326932" class="anchor"></span><div class="para"> <p>Interleukin-6 (IL-6) inhibitors‡</p></div></p></td></tr><tr class="even"><td><span id="v41326935" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sarilumab</span></p></div></td><td><span id="v41326937" class="anchor"></span><div class="para"> <p>200 mg subcutaneously once every 2 weeks</p></div><span id="v41326938" class="anchor"></span><div class="para"> <p>Dosage can be reduced to 150 mg once every 2 weeks</p></div></td><td><span id="v41326940" class="anchor"></span><div class="para"> <p>Neutropenia</p></div><span id="v41326941" class="anchor"></span><div class="para"> <p>Thrombocytopenia</p></div><span id="v41326942" class="anchor"></span><div class="para"> <p>Transaminase elevation</p></div></td></tr><tr class="odd"><td><span id="v41326945" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tocilizumab</span> </p></div></td><td><span id="v41326947" class="anchor"></span><div class="para"> <p>8 mg/kg IV every 4 weeks, to a maximum 800 mg/dose</p></div><span id="v41326948" class="anchor"></span><div class="para"> <p><i>or</i></p></div><span id="v41326949" class="anchor"></span><div class="para"> <p>162 mg subcutaneously every other week followed by an increase to every week based on clinical response in patients weighing < 100="" kg=""></p></div><span id="v41326950" class="anchor"></span><div class="para"> <p>162 mg subcutaneously every week in patients weighing > 100 kg</p></div></td><td><span id="v41326952" class="anchor"></span><div class="para"> <p>Potential risk of infection (particularly opportunistic organisms) </p></div><span id="v41326953" class="anchor"></span><div class="para"> <p>Neutropenia</p></div><span id="v41326954" class="anchor"></span><div class="para"> <p>Thrombocytopenia</p></div><span id="v41326955" class="anchor"></span><div class="para"> <p>Gastrointestinal perforation</p></div><span id="v41326956" class="anchor"></span><div class="para"> <p>Anaphylaxis</p></div><span id="v41326957" class="anchor"></span><div class="para"> <p>Transaminase elevation</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657881" class="anchor"></span><div class="para"> <p>Interleukin-1 (IL-1) receptor inhibitor‡</p></div></p></td></tr><tr class="odd"><td><span id="v29657884" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Anakinra</span></p></div></td><td><span id="v29657886" class="anchor"></span><div class="para"> <p>100 mg subcutaneously once/day</p></div></td><td><span id="v29657888" class="anchor"></span><div class="para"> <p>Injection site reactions</p></div><span id="v29657889" class="anchor"></span><div class="para"> <p>Immunosuppression</p></div><span id="v29657890" class="anchor"></span><div class="para"> <p>Neutropenia</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657909" class="anchor"></span><div class="para"> <p>Tumor necrosis factor (TNF)-alpha antagonists‡</p></div></p></td></tr><tr class="odd"><td><span id="v29657912" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span></p></div><span id="v48477189" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-atto</p></div><span id="v48477190" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-adbm </p></div><span id="v48477191" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-adaz </p></div><span id="v48477192" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-bwwd</p></div><span id="v48477193" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Adalimumab</span>-afzb</p></div></td><td><span id="v29657914" class="anchor"></span><div class="para"> <p>40 mg subcutaneously once every 2 weeks</p></div></td><td rowspan="5"><span id="v29657916" class="anchor"></span><div class="para"> <p>Potential risk of reactivation of infection (particularly tuberculosis and fungal infections) </p></div><span id="v41326958" class="anchor"></span><div class="para"> <p>Reactivation of hepatitis B</p></div><span id="v29657917" class="anchor"></span><div class="para"> <p>Nonmelanoma skin cancers</p></div><span id="v29657919" class="anchor"></span><div class="para"> <p>Antinuclear antibodies with or without clinical systemic lupus erythematosus (SLE)</p></div><span id="v29657920" class="anchor"></span><div class="para"> <p>Demyelinating neurologic disorders</p></div><span id="v41326959" class="anchor"></span><div class="para"> <p>Heart failure worsening</p></div></td></tr><tr class="even"><td><span id="v29657923" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Certolizumab pegol</span></p></div></td><td><span id="v29657925" class="anchor"></span><div class="para"> <p>400 mg subcutaneously (as 2 subcutaneous injections of 200 mg) once and then repeat at week 2 and week 4, followed by 200 mg subcutaneously every 2 weeks (or 400 mg subcutaneously every 4 weeks)</p></div></td></tr><tr class="odd"><td><span id="v29657928" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Etanercept</span></p></div><span id="v48477194" class="anchor"></span><div class="para"> <p><b>Biosimilars:</b></p></div><span id="v29657929" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Etanercept</span>-szzs </p></div><span id="v48477195" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Etanercept</span>-ykro</p></div></td><td><span id="v29657931" class="anchor"></span><div class="para"> <p>50 mg subcutaneously once/week</p></div></td></tr><tr class="even"><td><span id="v29657934" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Golimumab</span></p></div></td><td><span id="v29657936" class="anchor"></span><div class="para"> <p>50 mg subcutaneously once every 4 weeks</p></div></td></tr><tr class="odd"><td><span id="v29657939" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span></p></div><span id="v48477196" class="anchor"></span><div class="para"> <p><b>Biosimilars:</b></p></div><span id="v29657940" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span>-dyyb</p></div><span id="v48477197" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span>-abda</p></div><span id="v48477198" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span>-qbtx</p></div><span id="v48477199" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Infliximab</span>-axxq</p></div></td><td><span id="v29657942" class="anchor"></span><div class="para"> <p>3-mg/kg IV infusion in saline at baseline, at 2 weeks, and at 6 weeks with subsequent injections every 8 weeks (dosage may be increased to 10 mg/kg)</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v29657946" class="anchor"></span><div class="para"> <p>Janus kinase (JAK) inhibitors‡</p></div></p></td></tr><tr class="odd"><td><span id="v41326960" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Baricitinib</span></p></div></td><td><span id="v41326961" class="anchor"></span><div class="para"> <p>2 mg orally once/day</p></div></td><td><span id="v29657953" class="anchor"></span><div class="para"> <p>Risk of infection, particularly varicella-zoster virus reactivation</p></div><span id="v29657954" class="anchor"></span><div class="para"> <p>Nonmelanoma skin cancers</p></div><span id="v29657955" class="anchor"></span><div class="para"> <p>Hypercholesterolemia</p></div><span id="v41326962" class="anchor"></span><div class="para"> <p>Venous thromboembolism</p></div><span id="x000068" class="anchor"></span><div class="para"> <p>Major adverse cardiovascular events</p></div><span id="x000115" class="anchor"></span><div class="para"> <p>Lung cancer</p></div></td></tr><tr class="even"><td><span id="v41326965" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tofacitinib</span></p></div></td><td><span id="v41326967" class="anchor"></span><div class="para"> <p>5 mg orally 2 times a day</p></div></td><td><span id="v41326969" class="anchor"></span><div class="para"> <p>Risk of infection, particularly varicella-zoster virus reactivation</p></div><span id="v41326970" class="anchor"></span><div class="para"> <p>Nonmelanoma skin cancers</p></div><span id="v41326971" class="anchor"></span><div class="para"> <p>Hypercholesterolemia</p></div><span id="v48477200" class="anchor"></span><div class="para"> <p>Venous thromboembolism</p></div><span id="x000067" class="anchor"></span><div class="para"> <p>Major adverse cardiovascular events </p></div><span id="x000116" class="anchor"></span><div class="para"> <p>Lung cancer</p></div></td></tr><tr class="odd"><td><span id="v48477203" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Upadacitinib</span> </p></div></td><td><span id="v48477205" class="anchor"></span><div class="para"> <p>15 mg orally once/day</p></div></td><td><span id="v48477207" class="anchor"></span><div class="para"> <p>Risk of infection, particularly varicella-zoster virus reactivation </p></div><span id="v48477208" class="anchor"></span><div class="para"> <p>Nonmelanoma skin cancers </p></div><span id="v48477209" class="anchor"></span><div class="para"> <p>Hypercholesterolemia </p></div><span id="v48477210" class="anchor"></span><div class="para"> <p>Venous thromboembolism</p></div><span id="x000066" class="anchor"></span><div class="para"> <p>Major adverse cardiovascular events</p></div><span id="x000117" class="anchor"></span><div class="para"> <p>Lung cancer</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v29657714" class="anchor"></span><div class="para"> <p>* <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sulfasalazine</span> is usually given as enteric-coated tablets.</p></div></td></tr><tr><td colspan="3"><span id="v29657717" class="anchor"></span><div class="para"> <p>† During dosage increases for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>azathioprine</span>, complete blood count, aspartate aminotransferase, and alanine aminotransferase are monitored.</p></div></td></tr><tr><td colspan="3"><span id="v29657720" class="anchor"></span><div class="para"> <p>‡ These drugs are biologic agents.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>